<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474920</article-id><article-id pub-id-type="pmcid-ver">PMC12474920.1</article-id><article-id pub-id-type="pmcaid">12474920</article-id><article-id pub-id-type="pmcaiid">12474920</article-id><article-id pub-id-type="pmid">41006318</article-id><article-id pub-id-type="doi">10.1038/s41598-025-03152-y</article-id><article-id pub-id-type="publisher-id">3152</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antimicrobial, synergistic and antibiofilm activities of <italic toggle="yes">Myristica fragrans</italic> Houtt. Bioactive compounds and their derivatives</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kaur</surname><given-names initials="V">Vishaldeep</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kaushal</surname><given-names initials="S">Sonia</given-names></name><address><email>drsonia@pau.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kalia</surname><given-names initials="A">Anu</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jangra</surname><given-names initials="R">Raman</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sharma</surname><given-names initials="P">Purshotam</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qbzdk74</institution-id><institution-id institution-id-type="GRID">grid.412577.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 2352</institution-id><institution>Department of Chemistry, </institution><institution>Punjab Agricultural University, </institution></institution-wrap>Ludhiana, Punjab India </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qbzdk74</institution-id><institution-id institution-id-type="GRID">grid.412577.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 2352</institution-id><institution>Department of Microbiology, Electron Microscopy and Nanoscience Laboratory, </institution><institution>PAU, </institution></institution-wrap>Ludhiana, Punjab India </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04p2sbk06</institution-id><institution-id institution-id-type="GRID">grid.261674.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 5640</institution-id><institution>Department of Chemistry and Centre for Advanced Studies in Chemistry, </institution><institution>Panjab University, </institution></institution-wrap>Chandigarh, India </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>33041</elocation-id><history><date date-type="received"><day>15</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 15:25:44.047"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_3152.pdf"/><abstract id="Abs1"><p id="Par1">This study investigates the antimicrobial efficacy, synergistic interactions, antibiofilm activity, molecular docking studies, and drug-likeness properties of &#945;-terpineol, 4-carvomenthenol, and their derivatives isolated from nutmeg and mace (<italic toggle="yes">Myristica fragrans</italic> Houtt.). &#945;-Terpineol and 4-carvomenthenol were isolated from nutmeg essential oil and mace oleoresin respectively using column chromatography. Derivatization of &#945;-Terpineol was derivatized into its ester, epoxide, ether, and allylic bromide while 4-carvomenthenol was derivatized to form its ester and epoxide. The antimicrobial activity of isolated compounds and their derivatives was assessed against <italic toggle="yes">Bacillus sp</italic>., <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Yersinia enterocolitica</italic> and <italic toggle="yes">Escherichia coli</italic> followed by testing of their synergistic interactions with streptomycin. Additionally, the antibiofilm activity of the most effective treatments alone and in combination with was tested in combination with streptomycin was also evaluated. Molecular docking studies were conducted to assess binding affinities of the most effective treatments for DNA gyrase and transpeptidase followed byADMET profiling to evaluate their drug-likeness. The ester derivatives of &#945;-terpineol and 4-carvomenthenol demonstrated the highest antibacterial potential with MIC values ranging from 40 to 170&#160;&#181;g/ml. Both the ester derivatives showed significant synergistic interactions with streptomycin and exhibited strong to intermediate antibiofilm activity against all the tested bacteria. Molecular docking studies indicated favorable binding affinities (&#8211;6.56 to &#8722;&#8201;4.31&#160;kcal/mol) of ester derivatives for DNA gyrase and transpeptidase as compared to their parent compounds having favorable physicochemical properties, meeting drug-likeness criteria. &#945;-Terpineol ester and 4-carvomenthenol ester exhibited promising antimicrobial potential, synergistic interaction with streptomycin and antibiofilm properties, suggesting their potential as novel therapeutic agents. Further development and investigation of these compounds are warranted to explore their applications in clinical settings.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-03152-y.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>&#945;-terpineol, 4-carvomenthenol</kwd><kwd>Antimicrobial</kwd><kwd>Synergistic interaction</kwd><kwd>Molecular docking</kwd><kwd>Antibiofilm</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Drug discovery</kwd><kwd>Health care</kwd><kwd>Chemistry</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par3">Contamination of food by microbes results in widespread illness, creating significant economic loss and public health challenges worldwide<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Foodborne illness constitutes a significant health concern in developing nations today, impacting nearly 600&#160;million individuals annually, with approximately 4,20,000 deaths reported yearly<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The World Health Organization (WHO) estimated that combined foodborne and waterborne diarrheal diseases contributed to approximately 2.2&#160;million deaths globally, affecting around 1&#160;million individuals annually in the United Kingdom.</p><p id="Par4">During the past three decades, new synthetic antibiotics have been manufactured by pharmaceutical industries to cure microbial infections. The use of such synthetic antibiotics always remains questionable due to their side effects<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. The treatment of various microbial infections has become more challenging due to the increased resistance of bacterial pathogens against synthetic antibiotics<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Hence, it becomes necessary to search for new antimicrobial agents to combat these food-borne pathogens to extend the shelf life of food commodities, improve consumers&#8217; health, reduce food wastage, and make the food business cost-effective.</p><p id="Par5">Antimicrobial agents from natural sources like plants, animals and microorganisms serve as an alternative to these synthetic chemicals to ensure food safety without affecting the sensory qualities of food products<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. They also contribute to enhance the nutritional value of food products and provide suitable alternatives to microbial resistance caused by antibiotics<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Hence, in this stressful daily routine with an unbalanced nutritional diet and even increasing rate of various chronic diseases, it becomes important to conduct studies on natural products of plant origin as antimicrobial agents to satisfy health-conscious consumers<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par6">Herbs and spices having numerous health benefits have gained a lot of attention to explore the antimicrobial potential of various bioactive compounds present in them<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Different bioactive compounds found in them work synergistically with one another and with the target enzymes or proteins of microbes. This interaction supports the immune system and serves as potential source of new chemical scaffolds for drug development<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Terpenoids constitute one such important class of bioactive compounds having huge biological potential involving antimicrobial properties<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The antimicrobial properties of diverse terpenoids stem from their inherent lipophilic nature, enabling them to effortlessly penetrate the cell membrane of microorganisms<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. They have strong permeation-enhancing potential and have been generally recognized as safe (GRAS) adjuvants with relatively low and transient irritation<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>.</p><p id="Par7">&#945;-Terpineol and 4-carvomenthenol are monocyclic monoterpene alcohols found naturally in essential oils of several plants such as nutmeg tree, oregano, rosemary, marjoram and lemon peel<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Due to their pleasant lilac-like scent, they are commonly used in the production of cosmetics, soaps, perfumes, and antiseptic products, making them one of the most popular fragrance compounds. Additionally, their acetate derivatives and other simple esters are also utilized in perfumes and aromatic fragrances<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Moreover, &#945;-terpineol and 4-carvomenthenol possess numerous biological and pharmacological properties such as antiulcer, antioxidant, anticancer, anticonvulsant, anti-inflammatory, insecticidal, antimicrobial and antinociceptive<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref></sup>. Both the compounds i.e., &#945;-terpineol and 4-carvomenthenol showed antibacterial activity due to the presence of the hydroxyl group which can exchange protons and form hydrogen bonds with the electron-delocalized system enabling terpenoids to interact with microbial plasma membranes. This interaction induces conformational changes in the membrane structure, leading to ion imbalance, leakage, and ultimately cell death<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>. Moreover, the hydroxyl group found in terpenoids also contributes to a reduction in pH gradient across the cell membrane. This reduction leads to the collapse of the proton motive force and depletion of the ATP pool, ultimately culminating in cell death<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par8">Till date numerous researchers have reported the antibacterial potential of &#945;-terpineol and 4-carvomenthenol<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> but very few studies have been done on testing the antibacterial activity of their derivatives<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> along with investigation of their synergistic interaction with standard antibiotic as well as antibiofilm potential. Thus, in continuation with our previous study<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, in the present study, we have isolated &#945;-terpineol and 4-carvomenthenol from two unique spices i.e., nutmeg (seed) and mace (skin of nutmeg seed) commonly named as &#8216;Jaiphal&#8217; and &#8216;Javatri&#8217; respectively, prepared their derivatizes and tested their antibacterial activity. The study was further extended to investigate theirs&#8217; and the most effective derivative&#8217;s synergistic interaction with standard antibiotic, the antibiofilm activity of the most effective treatment; molecular docking studies to determine their binding affinity with DNA gyrase and transpeptidase, toxicity and drug-like properties analysis through absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies.</p><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Chemicals and reagents</title><p id="Par9">All the chemicals and reagents including hexane, ethyl acetate, dichloromethane, ethanol, pyridine, acetyl chloride, copper sulfate, silica gel, oxone, sodium bicarbonate, magnesium sulfate, acetone, n-propyl bromide, n-bromosuccinamide, carbon tetrachloride, dimethyl sulfoxide and crystal violet dye were of analytical grade and purchased from Sigma AdrichChemicals Pvt. Limited, Delhi. Standard antibiotic streptomycin was purchased from LobaChemie Pvt. Limited, Mumbai.</p></sec><sec id="Sec4"><title>Extraction and characterization of plant material</title><p id="Par10">The extraction of nutmeg and mace essential oils by hydrodistillation method using Clevenger type apparatus and their oleoresins by Soxhlet extraction using ethanol as a solvent along with the testing of their antibacterial activity was done as per the methodology described in our previous communication<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Gas chromatography-mass spectrometry (GC-MS) analysis of nutmeg essential oil and mace oleoresin showing maximum antibacterial activity was also carried out with an Agilent 7890&#160;A GC fitted with an HP-5MS column (30&#160;m &#215; 0.25&#160;mm &#215; 0.25&#160;&#956;m). Nitrogen, with a purity of 99.99%, served as the carrier gas at a flow rate of 1&#160;ml/min. The test components were diluted in n-hexane (1&#160;&#181;l/ml) and 1.0&#160;&#181;l of this solution was injected into the column (1&#160;&#181;l/min) using a split mode ratio of 1:10. The injector temperature was set at 250&#160;&#176;C. The temperature programme for the oven was as follows: initially kept at 50<sup>&#176;</sup>C for 2&#160;min, then increased to 120&#160;&#176;C at the rate of 4&#160;&#176;C/min and maintained for 5&#160;min, followed by rise to 230&#160;&#176;C (10&#160;&#176;C/min) for 10&#160;min and finally raised to 280<sup>&#959;</sup>C (20&#160;&#176;C/min) for 5&#160;min where it was held constant for additional 10&#160;min. Various MS parameters for the analysis were set on an Agilent MSD5975C MS detector with a detector voltage of 1.5&#160;V, an ionization voltage of 70&#160;eV and a mass range 45&#8211;600 amu. The identification of components was achieved by comparing their mass spectra with those in the NIST08 and WILEY8 libraries as well as National Building Specifications (NBS) database libraries (Table <xref rid="MOESM1" ref-type="media">S1</xref>, S2 and Fig. <xref rid="MOESM1" ref-type="media">S1</xref>, S2). The retention indices (RI) were calculated using a series of homologous n-alkane (C<sub>7</sub>-C<sub>40</sub>) under the same chromatographic conditions. To confirm the compounds, the RI values obtained were compared with those in the literature<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> (Adam 2007) and were calculated using the formula:<disp-formula id="Equa"><alternatives><tex-math id="d33e347">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{I}}={\text{1}}00 \times \left[ {{\text{n}}+\frac{{\log {{\text{t}}_{\text{x}}} - \log {{\text{t}}_{\text{n}}}}}{{\log {{\text{t}}_{{\text{n}}+1}} - \log {{\text{t}}_{\text{n}}}}}} \right]$$\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="41598_2025_3152_Article_Equa.gif"/></alternatives></disp-formula></p><p id="Par12">Where t<sub>x</sub>= retention time of sample, t<sub>n</sub> and t<sub><italic toggle="yes">n</italic>+1</sub>= Retention time of alkane standard having n, <italic toggle="yes">n</italic>&#8201;+&#8201;1 carbons respectively.</p><p id="Par13">Relative proportions of components in the essential oil were also measured using an Agilent 7890&#160;A-GC-FID, under the same conditions as those used for GC-MS. Nitrogen was employed as the carrier gas at a flow rate of 1&#160;ml/min. The injector and detector temperatures were set at 250 and 300&#160;&#176;C respectively. The relative proportions of the components were calculated by dividing the area of each individual peak by the total area of all peaks, without considering the response factor.</p></sec><sec id="Sec5"><title>Isolation of &#945;-terpineol from nutmeg essential oil</title><p id="Par14">The nutmeg essential oil showing the maximum antibacterial potential<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> revealed the presence of &#945;-terpineol (23.02%) in GC-MS analysis as a major compound which was further isolated <italic toggle="yes">via</italic> column chromatography. For this, the nutmeg essential oil (10&#160;g) was chromatographed over silica gel (600&#160;g). The column was eluted with hexane and polarity was increased gradually using dichloromethane (DCM). Fractions obtained by using hexane: dichloromethane (80:20) and (70:30) were pooled and further subjected to a second column using silver nitrate impregnated silica gel. Elution of the column was carried out with hexane: ethyl acetate as a solvent system of increasing polarity<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Each fraction was assessed by using TLC. The &#945;-terpineol was obtained as a pure compound (2.06&#160;g) in fractions (95:5 and 94:6). The characterization of pure compound (I) thus obtained was done by spectroscopic analysis.</p></sec><sec id="Sec6"><title>Isolation of 4-carvomenthenol from Mace Oleoresin</title><p id="Par15">GC-MS analysis of mace oleoresin revealed the presence of major compound 4-carvomenthenol (12.40%) as a major compound which was further isolated <italic toggle="yes">via</italic> column chromatography. The mace oleoresin (10&#160;g) was chromatographed over silica gel (600&#160;g) and eluted with hexane and polarity was increased gradually using dichloromethane. Fractions obtained by using hexane: dichloromethane (90:10) and (80:20) as a solvent system were pooled and further subjected to second column having 200&#160;g of silver nitrate impregnated silica gel using hexane: ethyl acetate as a solvent system of increasing polarity<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Each fraction was assessed by using TLC. The 4-carvomenthenol was obtained as a pure compound (1.04&#160;g) in fraction with solvent ratio of 97:3. The characterization of pure compound (II) thus obtained was done by spectroscopic analysis.</p></sec><sec id="Sec7"><title>Derivatization of &#945;-terpineol</title><sec id="Sec8"><title>Esterification of &#945;-terpineol</title><p id="Par16">To prepare the ester from &#945;-terpineol, 1.0&#160;g (6.5 mmol) of &#945;-terpineol was mixed with 2.0&#160;ml of acetyl chloride, followed by the addition of 2&#160;ml of pyridine. The resulting blend was stirred at room temperature for 24&#160;h. Subsequently, ethyl acetate (20&#160;ml) was introduced into the reaction mixture, which was then partitioned with 20% w/v aqueous solution of copper sulfate pentahydrate (CuSO<sub>4</sub>&#183;5H<sub>2</sub>O) in three 30&#160;ml portions. After separating the organic (ethyl acetate) and aqueous phases, the organic phase was treated with a saturated solution of sodium chloride and then with anhydrous magnesium sulfate (MgSO<sub>4</sub>) to remove any residual water (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A). A brown-colored solid product was obtained after evaporating the solvent with a rotary evaporator<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The product was purified by recrystallization using ethanol, the purity of the resulting compound (III) was assessed using TLC, and its structure was determined through spectroscopic techniques. The yield of purified compound (III) was calculated on weight (w/w) basis.</p><p>
<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Synthetic routes for different derivatives; (<bold>A</bold>) compound (III), (<bold>B</bold>) compound (IV), (<bold>C</bold>) compound (V), (<bold>D</bold>) compound (VI), (<bold>E</bold>) compound (VII) and (<bold>F</bold>) compound (VIII).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig1a_HTML.jpg"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO100" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig1b_HTML.jpg"/></fig>
</p></sec><sec id="Sec9"><title>Epoxidation of &#945;-terpineol</title><p id="Par18">In order to synthesize &#945;-terpineol epoxide, 0.8&#160;g (5 mmol) of &#945;-terpineol was mixed in 15&#160;ml of acetone having 2.0&#160;g (23.8 mmol) of sodium bicarbonate (NaHCO<sub>3</sub>). The solution was allowed to cool at 0&#160;&#176;C. Subsequently, a solution of oxone (2KHSO<sub>5</sub>&#183;KHSO<sub>4</sub>&#183;K<sub>2</sub>SO<sub>4</sub>, 4&#160;g; 6.5 mmol) in 15&#160;ml of water was slowly added to the cooled mixture. Once the reaction was complete (after 8&#160;h), the resulting mixture was shifted into the separatory funnel and extracted with diethyl ether (2&#8201;&#215;&#8201;25&#160;ml). The combined ether layers were dried over anhydrous sodium sulfate (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B). Evaporation of the solvent yielded colorless needle-shaped crystals of the resulting product<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The resulting compound (IV) was purified using preparative TLC (hexane: ethyl acetate; 90:10), and its structure was determined through spectroscopic techniques. The yield of purified compound (IV) was calculated on weight (w/w) basis.</p></sec><sec id="Sec10"><title>Williamson ether synthesis of &#945;-terpineol</title><p id="Par19">1.5&#160;g (10 mmol) of &#945;-terpineol, 20&#160;ml of dimethyl sulfoxide (DMSO) and 5.0&#160;g (125 mmol) of NaOH were heated at 90&#8211;110&#160;&#176;C with constant stirring. After the precipitates changed their appearance from slimy form to granular, 5.5&#160;ml of n-propyl bromide was added slowly by maintaining the temperature at 100&#160;&#176;C. The reaction was continued for 8&#8211;9&#160;h. The reaction mixture was then allowed to cool down followed by sufficient addition of water to mix the precipitates. The extraction of the aqueous phase was done thrice with diethyl ether and any moisture left was removed by anhydrous sodium sulfate followed by ether removal by distillation (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. The resulting compound was purified using preparative TLC (hexane: ethyl acetate; 80:10). The structure of the final compound (V) obtained was determined by spectroscopic techniques and its yield was calculated on weight (w/w) basis.</p></sec><sec id="Sec11"><title>Allylic bromination of &#945;-terpineol</title><p id="Par20">To carry out the allylic bromination, 0.16&#160;g (1.0 mmol) of n-bromosuccinamide was added to 1.4&#160;g (10 mmol) of &#945;-terpineol with 10&#160;mg (0.05 mmol) of benzoyl peroxide as a catalyst. The reaction mixture was added to 10&#160;ml of carbon tetrachloride as a solvent and heated for 15&#160;h at 85&#160;&#176;C with constant stirring. The red-colored reaction mixture obtained was cooled and the solid material formed was filtered away. To the filtrate, 50&#160;ml diethyl ether was added and washed with sodium bicarbonate solution and sodium sulphite (50&#160;ml; 1:1) in a separatory funnel. The organic layer was separated followed by drying with anhydrous MgSO<sub>4</sub>. The organic layer was then evaporated and a concentrated mixture of products was obtained. The brominated product formed was isolated and purified through preparative TLC using hexane: ethyl acetate (80:20) as the mobile phase (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>D)<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Finally, the structure of the compound (VI) obtained was determined by spectroscopic techniques and its yield was calculated on weight (w/w) basis.</p></sec></sec><sec id="Sec12"><title>Derivatization of 4-carvomenthenol</title><sec id="Sec13"><title>Esterification of 4-carvomenthenol</title><p id="Par21">To prepare the ester, 1.0&#160;g (6.5 mmol) of 4-carvomenthenol was mixed with 2.0&#160;ml of acetyl chloride, followed by the addition of 2&#160;ml of pyridine. The resulting blend was stirred at room temperature for 24&#160;h. Subsequently, ethyl acetate (20&#160;ml) was introduced into the reaction mixture, which was then partitioned with a 20% w/v aqueous solution of copper sulfate pentahydrate (CuSO<sub>4</sub>&#183;5H<sub>2</sub>O) in three 30&#160;ml portions. After separating the organic (ethyl acetate) and aqueous phases, the organic layer was treated with NaCl solution (saturated) and then with anhydrous MgSO<sub>4</sub> to remove any residual water (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>E). A brown-colored solid product was obtained after evaporating the solvent by rotary evaporator<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The product was purified by recrystallization using ethanol, the purity of the resulting compound (VII) was assessed using TLC, and its structure was determined through spectroscopic techniques. The yield of purified compound (VII) was calculated on weight (w/w) basis.</p></sec><sec id="Sec14"><title>Epoxidation of 4-carvomenthenol</title><p id="Par22">To synthesize 4-carvomenthenol epoxide, 0.8&#160;g (5 mmol) of 4-carvomenthenol was mixed in 15&#160;ml of acetone having 2.0&#160;g (23.8 mmol) of NaHCO<sub>3</sub>. The solution was allowed to cool at 0&#160;&#176;C. Subsequently, a solution of oxone (2KHSO<sub>5</sub>&#183;KHSO<sub>4</sub>&#183;K<sub>2</sub>SO<sub>4</sub>, 4&#160;g; 6.5 mmol) in 15&#160;ml of water was slowly added to the cooled mixture. Once the reaction was complete (after 8&#160;h), the resulting mixture was shifted into the separatory funnel and extracted with diethyl ether two times (2&#8201;&#215;&#8201;25&#160;ml). The combined ether layers were dried over anhydrous sodium sulfate (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>F). Evaporation of the solvent yielded colorless needle-shaped crystals of the resulting product<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The resulting compound (IV) was purified using preparative TLC (hexane: ethyl acetate; 9:1), and its structure was determined through spectroscopic techniques. The yield of purified compound (VIII) was calculated on weight (w/w) basis.</p><p id="Par23">The physical properties and spectroscopic data of isolated compounds (I) and (II) and their derivative compounds (III-VIII) have been given below:</p><p id="Par24">Compound (I): Color: Colorless viscous liquid, mp: 30&#8211;32&#160;&#176;C, yield: 35%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3363, 2965, 2922, 1660, 1436, 1375, 1155, <sup>1</sup>HNMR signal (500&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 5.28&#8211;5.29 (m, 1&#160;H), 1.98 (s, 1&#160;H), 1.78&#8211;1.92 (m, 4&#160;H), 1.40&#8211;1.44 (m, 1&#160;H), 1.06&#8211;1.09 (m, 2&#160;H), 1.56 (s, 3&#160;H), 1.09 (s, 3&#160;H), 1.07 (s, 3&#160;H) (Figs. S3-S4).</p><p id="Par25">Compound (II): Color: Colorless viscous liquid, mp: 14&#8211;15&#160;&#176;C, yield: 22%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3445, 2959, 2912, 2879, 1677, 1436, 1377, 1161, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 5.28&#8211;5.30 (m, 1&#160;H), 1.91 (s, 1&#160;H), 1.58&#8211;1.62 (m, 4&#160;H), 2.13&#8211;2.14 (m, 2&#160;H), 1.45&#8211;1.58 (m, 1&#160;H), 1.67 (s, 3&#160;H), 0.92 (d, 6&#160;H, J&#8201;=&#8201;2.72&#160;Hz) (Figs. S5-S6).</p><p id="Par26">Compound (III): Color: Brown, mp: 29&#8211;30&#160;&#176;C, yield: 46%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 2931, 2870, 1733, 1617, 1440, 1369, 1228, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 5.26&#8211;5.36 (m, 1&#160;H), 1.63&#8211;1.68 (m, 4&#160;H), 1.97&#8211;2.05 (m, 1&#160;H), 1.51&#8211;1.57 (m, 2&#160;H), 1.18 (s, 3&#160;H), 1.60&#8211;1.62 (m, 6&#160;H), 3.02 (s, 3&#160;H) (Figs. S7-S8).</p><p id="Par27">Compound (IV): Color: Colorless crystals, mp: 72&#160;&#176;C, yield: 35%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3334, 2920, 1457, 1373, 1276, 1125, 982, 836, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 3.14&#8211;3.15 (m, 1&#160;H), 1.29&#8211;1.34 (m, 4&#160;H), 1.35&#8211;1.41 (m, 1&#160;H), 1.23&#8211;1.25 (m, 2&#160;H), 1.18 (s, 3&#160;H), 1.12&#8211;1.15 (m, 6&#160;H), 2.07 (s, 1&#160;H) (Figs. S9-S10).</p><p id="Par28">Compound (V): Color: Dark brown viscous liquid, mp: 40&#160;&#176;C, yield: 50%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 2961, 2924, 2871, 1669, 1448, 1263, 982, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 5.28&#8211;5.32 (m, 1&#160;H), 2.30&#8211;2.33 (m, 4&#160;H), 2.20&#8211;2.25 (m, 1&#160;H), 1.21&#8211;1.24 (m, 2&#160;H), 1.64 (s, 3&#160;H), 1.04&#8211;1.18 (m, 6&#160;H), 3.44 (t, 2&#160;H, J&#8201;=&#8201;12.8&#160;Hz), 2.84&#8211;2.85 (m, 2&#160;H), 1.19 (t, 3&#160;H, J&#8201;=&#8201;3.04&#160;Hz) (Figs. S11-S12).</p><p id="Par29">Compound (VI): Color: Dark orange liquid, mp: 95&#160;&#176;C, yield: 35%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3395, 3012, 2933, 1645, 1436, 1388, 1099, 661, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 4.83&#8211;4.86 (m, 1&#160;H), 2.91&#8211;2.95 (m, 1&#160;H), 2.86&#8211;2.87 (m, 1&#160;H), 1.73&#8211;1.75 (m, 2&#160;H), 2.79&#8211;2.83 (m, 2&#160;H), 1.56 (s, 3&#160;H), 1.15 (s, 6&#160;H), 1.99 (s, 1&#160;H) (Figs. S13-S14).</p><p id="Par30">Compound (VII): Color: Brown, mp: 29&#8211;30&#160;&#176;C, yield: 42%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3056, 2918, 1712, 1265, 1636, 1418, 1362, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 5.19&#8211;5.27 (m, 1&#160;H), 2.04&#8211;2.05 (m, 2&#160;H), 1.96&#8211;1.97 (m, 2&#160;H), 2.00-2.02 (m, 2&#160;H), 1.18 (s, 3&#160;H), 2.53&#8211;2.55 (m, 1&#160;H), 1.16 (d, 6&#160;H, J&#8201;=&#8201;4.28&#160;Hz), 1.93 (s, 3&#160;H) (Figs. S15-S16).</p><p id="Par31">Compound (VIII): Color: Colorless crystals, mp: 70&#160;&#176;C, yield: 30%, FT-IR Band (cm<sup>&#8722;&#8201;1</sup>): 3267, 2924, 1418, 1362, 1146, 1246, 924, 818, <sup>1</sup>HNMR signal (400&#160;MHz, CDCl<sub>3</sub>) (&#948; in ppm): 2.92&#8211;2.95 (m, 1&#160;H), 1.91&#8211;1.93 (m, 2&#160;H), 1.64&#8211;1.65 (m, 2&#160;H), 1.73&#8211;1.74 (m, 2&#160;H), 1.31 (s, 3&#160;H), 1.95&#8211;1.98 (m, 1&#160;H), 0.89 (d, 6&#160;H, J&#8201;=&#8201;1.2&#160;Hz), 2.31 (s, 1&#160;H) (Figs. S17-S18).</p></sec></sec><sec id="Sec15"><title>Antibacterial activity of isolated pure compounds and their derivatives</title><p id="Par32">The antibacterial potential of &#945;-terpineol, 4-carvomenthenol and their derivatives was screened against <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Y. enterocolitica</italic>, <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Bacillus</italic> sp. by agar well diffusion method (concentration range 50&#8211;1000&#160;&#181;g/ml) as per the methodology given in our previous communication<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p></sec><sec id="Sec16"><title>Cell constituent release study</title><p id="Par33">The release of constituents from the bacterial cells into the supernatant was studied as per the method given by Heena et al.<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> with minor modifications. The cells were collected by centrifugation of 100&#160;ml of bacterial cultures for 10&#160;min at 5000&#160;rpm followed by their washing with double distilled water (three times) and resuspension in 0.1&#160;M phosphate buffer saline (pH 7.0). Then 100&#160;ml of bacterial cell suspensions were treated with test compounds (I-VIII) at their MIC values and kept in incubator for 1&#160;h at 37&#160;&#176;C. From these, 2&#160;ml of the sample was taken and centrifuged for 2&#160;min at 12,000&#160;rpm. The cell constituent release was studied by observing the absorbance of 1&#160;ml of supernatant (from each sample) at 260&#160;nm under UV-Visible spectrophotometer (Perkin&#8211;Elmer 45). The absorption of the suspension, prepared with PBS (pH 7.0) and containing the same concentration of test compounds, was adjusted after 2&#160;min of contact with the test bacterial strains. The control cells (untreated) were similarly corrected with PBS (pH 7.0).</p></sec><sec id="Sec17"><title>Synergistic potential</title><p id="Par34">The synergistic or combined interaction of isolated pure compounds and their most effective derivatives with standard antibiotic (streptomycin) was assessed by employing the checkerboard method<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. This method involved diluting each treatment and the standard antibiotic in a 96-well microtiter plate, with two-fold dilutions ranging from MIC to 1/32 of MIC. Briefly, 50&#160;&#181;l of each treatment at MIC was combined with 50&#160;&#181;l of streptomycin at MIC with serial two-fold dilutions in Muller Hinton broth. Following this, a log-phase bacterial inoculum (100&#160;&#181;l) was inoculated to all the wells, and the plate was then kept in an incubator at 37&#160;&#176;C for 24&#160;h. The MIC of each treatment alone, the standard antibiotic alone, and their combinations were recorded. The results were analyzed using the fractional inhibitory concentration index (FICI) as:<disp-formula id="Equb"><alternatives><tex-math id="d33e634">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{FICI}}={\text{FI}}{{\text{C}}_{\text{A}}}+{\text{ FI}}{{\text{C}}_{\text{B}}}$$\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="41598_2025_3152_Article_Equb.gif"/></alternatives></disp-formula></p><p id="Par36">FIC<sub>A</sub> represented the MIC of each treatment in combination divided by the MIC of the treatment alone, while FIC<sub>B</sub> represented the MIC of the synthetic antibiotic in combination divided by the MIC of the antibiotic alone. Interpretation of the FICI values indicated the nature of the interaction between the treatments: FICI&#8201;&#8804;&#8201;0.5 indicated synergistic interaction, 0.5&#8201;&lt;&#8201;FICI&#8201;&#8804;&#8201;1 indicated an additive effect, 1&#8201;&lt;&#8201;FICI&#8201;&#8804;&#8201;4 indicated indifference or no effect, and FICI&#8201;&gt;&#8201;4 indicated antagonistic effects<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p></sec><sec id="Sec18"><title>Antibiofilm potential</title><p id="Par37">The test components showing the synergistic interaction with streptomycin against all the test bacteria was further studied for its antibiofilm activity, alone as well as in combination with streptomycin. The crystal violet method was used to assess the antibacterial mechanism by estimating the specific biofilm formation (SBF) by using UV- spectroscopy<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p><p id="Par38">To the test tubes, 5&#160;ml of nutrient broth was added, followed by the inoculation of 50&#160;&#181;l of microbial culture with an optical density (OD<sub>560</sub>) of 0.02 (equivalent to 10<sup>6</sup> CFU/ml). Subsequently, the most effective compound at its MIC as well as in combination with streptomycin was added. Only streptomycin-containing tubes served as the standard, while the tube without any compound acted as the control. The tubes were then kept undisturbed in the incubator for 48&#160;h at 37&#160;&#176;C to allow for ring formation. Following incubation, the supernatant was carefully removed using a micro-pipette, and each tube was properly washed three times with distilled water to eliminate any unadhered or planktonic cells. The tubes were then air-dried for 30&#160;min. Subsequently, 5&#160;ml of a 1% aqueous solution of crystal violet dye was added to each tube and left for 15&#160;min at room temperature. The dye solution was then discarded, and the tubes were gently washed three times with distilled water to remove excess stain. Next, 95% ethanol solution (5&#160;ml) was added to each tube and kept in incubator for 15&#160;min. Following this, the absorbance was noted at 570&#160;nm using a double beam UV spectrophotometer (Perkin&#8211;Elmer 45). The SBF value was measured using the formula:<disp-formula id="Equc"><alternatives><tex-math id="d33e663">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SBF}}=({\text{AB}} - {\text{CW}})/{\text{G}}$$\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="41598_2025_3152_Article_Equc.gif"/></alternatives></disp-formula></p><p id="Par40">where AB represents the OD at 570&#160;nm of the attached and stained bacteria, CW represents the OD at 570&#160;nm of the stained control tubes containing only bacteria-free medium, and G represents the OD at 630&#160;nm of cell growth in broth<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Further, there were three categories of SBF values:</p><p id="Par41">If strong biofilm is formed; SBF&#8201;&gt;&#8201;2.00.</p><p id="Par42">For intermediate biofilm; SBF range between 1 and 2.</p><p id="Par43">For weak biofilm formation; SBF&#8201;&lt;&#8201;1.00.</p></sec><sec id="Sec19"><title>Molecular docking studies</title><p id="Par44">Two enzymes DNA gyrase (PDB: 1KZN)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> and a transpeptidase, penicillin-binding protein 2a (PBP2a, PDB: 1MWT)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> were obtained from the Protein Data Bank for molecular docking studies. These enzymes were further prepared for docking by removing all water molecules and cognate ligands from PDB files and grid boxes of dimensions 100 &#197; &#215; 98 &#197; &#215; 90 &#197; (scaling factor: 0.475 &#197;) and 68 &#197; &#215; 54 &#197; &#215; 124 &#197; (scaling factor: 0.999 &#197;) were defined to accommodate the whole target enzymes, respectively using AutodockTools4<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. 3D structures of three compounds (&#945;-terpineol ester, 4-carvomenthenol ester and Streptomycin) were downloaded from PubChem (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov">https://pubchem.ncbi.nlm.nih.gov</ext-link>) and prepared by defining the root and assigning the Gasteiger charges using AutodockTools4<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. For both enzymes, our docking protocol employed AutoDock-GPU4 (v1.5) and consists of the 1000 iterations of gradient-based local search methods (ADADELTA)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, where the initial first generation was predicted by the Solis-Wets (SW) local search algorithm<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Further, 500 Lamarckian genetic algorithm (LGA)<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> runs for global search were included over a population of 300 individuals. The final analysis and visualization of the ligand binding site was done using PyMol<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> and Discovery Studio<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>.</p><p id="Par45">For validation of the adopted docking protocol, re-docking of the cognate ligands, clorobiocin and penicillin G was carried out into their respective target enzymes&#8212;DNA gyrase and PBP2a respectively. The RMSD values have also been determined to confirm the reliability of the model.</p></sec><sec id="Sec20"><title>Physiochemical and ADMET analysis</title><p id="Par46">The different pharmacokinetic properties of &#945;-terpineol ester and 4-carvomenthenol ester were investigated through ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) analysis, which offers crucial insights into the molecules&#8217; drug-ability potential<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. The present study involves the investigation of Lipinski parameters (physiochemical properties) ADMET profiles of ester derivatives. The 3D structures of both ester derivatives were converted to SMILES format using OpenBabel<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. These SMILES strings were fed into ADMETlab 3.0 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://admetlab3.scbdd.com/">https://admetlab3.scbdd.com/</ext-link>) to investigate their toxicity and pharmacokinetic properties.</p></sec><sec id="Sec21"><title>Statistical analysis</title><p id="Par47">The results were presented as mean values with their corresponding standard deviations. To investigate the antibacterial activity, ANOVA followed by Tukey&#8217;s B test was conducted using SAS, with statistical significance set at <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>.</p></sec></sec><sec id="Sec22"><title>Results and discussion</title><sec id="Sec23"><title>Isolation and derivatization of major compounds</title><p id="Par48">GC-MS analysis of nutmeg essential oil and mace oleoresin revealed &#945;-terpineol (23.02%) and 4-carvomenthenol (12.40%) as major compounds respectively (Table <xref rid="MOESM1" ref-type="media">S1</xref>, S2 and Fig. <xref rid="MOESM1" ref-type="media">S1</xref>, S1) which were isolated in pure form by column chromatography as colorless viscous liquids in solvent system of hexane: ethylacetate (95:1) and 97:3 respectively with yield of 35 and 22% respectively. The isolated &#945;-terpineol (I) was derivatized into &#945;-terpineol ester (III), &#945;-terpineol epoxide (IV), &#945;-terpineol ether (V), 3-Bromo terpineol (VI), and 4-carvomenthenol (II) was derivatized into 4-carvomenthenol ester (VII) and 4-carvomenthenol epoxide (VIII). The structure elucidation of isolated compounds and their derivatives was carried out by FT-IR and<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>HNMR spectroscopic techniques (Figs. S3-S18) and by reference to the published data in the literature<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR46">46</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref></sup>.</p></sec><sec id="Sec24"><title>Antibacterial activity of isolated and derivatized compounds</title><p id="Par49">The isolated major compounds i.e., &#945;-terpineol (I) and 4-carvomenthenol (II) and their derivatized compounds (III&#8211;VIII) were tested for their antibacterial activity where all the derivatives revealed greater antibacterial potential as compared to their parent compounds. The results were expressed in terms of inhibition zone diameter (Tables&#160;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref>, <xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>) and MIC values (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). All the test components revealed significant antibacterial activity being more effective towards Gram-positive bacteria than Gram-negative bacteria. It has been found that compound (VII) being 4-carvomenthenol ester showed a maximum zone of inhibition @1000 &#181;g/ml against Gram-positive bacteria i.e., 37.22 and 33.14&#160;mm against <italic toggle="yes">Bacillus</italic> sp. and <italic toggle="yes">S. aureus</italic> respectively (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>), whereas, compound (III) being &#945;-terpineol ester exhibited maximum zone of inhibition @1000 &#181;g/ml against Gram-negative bacteria i.e., 27.65 and 22.51&#160;mm against <italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">E. coli</italic> (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). From the MIC values, it has been observed that compound (VII) showed the MIC values of 40, 65, 145 and 170&#160;&#181;g/ml against <italic toggle="yes">Bacillus</italic> sp., <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">E. coli</italic> respectively. On the other hand, compound (III) showed the MIC values of 75, 105, 120 and 155&#160;&#181;g/ml respectively. Based upon the MIC values, the decreasing order of sensitivity of bacterial strains towards different test components followed the order: <italic toggle="yes">Bacillus</italic> sp. &gt; <italic toggle="yes">S. aureus</italic>&#8201;&gt;&#8201;<italic toggle="yes">Y. enterocolitica</italic>&#8201;&gt;&#8201;<italic toggle="yes">E. coli</italic>.</p><p id="Par50">The order of antibacterial activity of isolated major compounds and their derivatives against different test bacteria is as shown below:</p><p id="Par51">Streptomycin&#8201;&gt;&#8201;VII&#8201;&gt;&#8201;III&#8201;&gt;&#8201;V&#8201;&gt;&#8201;VIII&#8201;&gt;&#8201;IV&#8201;&gt;&#8201;VI&#8201;&gt;&#8201;II&#8201;&gt;&#8201;I (<italic toggle="yes">Bacillus</italic> sp. and <italic toggle="yes">S. aureus</italic>).</p><p id="Par52">Streptomycin&#8201;&gt;&#8201;III&#8201;&gt;&#8201;VII&#8201;&gt;&#8201;IV&#8201;&gt;&#8201;VIII&#8201;&gt;&#8201;VI&#8201;&gt;&#8201;V&#8201;&gt;&#8201;I&#8201;&gt;&#8201;II (<italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">E. coli</italic>).</p><p id="Par53">All the results were significantly different from each other (mean values with different superscripts) as analysed by two-way ANOVA followed by Tukey B test at significance level of <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05.</p><p>
<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>MIC values of isolated major compounds and their derivatives against all the test bacteria. Values with different superscripts represent the significant difference at <italic toggle="yes">p</italic> &lt; 0.05 using Tukey-B test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig2_HTML.jpg"/></fig>
</p><p>
<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Zone of inhibition by compound (VII) against <italic toggle="yes">Bacillus</italic> sp. (<bold>i</bold>), <italic toggle="yes">S. aureus</italic> (<bold>ii</bold>), <italic toggle="yes">Y. enterocolitica</italic> (<bold>iii</bold>) and <italic toggle="yes">E. coli</italic> (<bold>iv</bold>) @ 100 (<bold>A</bold>), 250 (<bold>B</bold>), 500 (<bold>C</bold>) and 1000&#160;&#181;g/ml (<bold>D</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig3_HTML.jpg"/></fig>
</p><p>
<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p> Zone of inhibition by compound (III) against <italic toggle="yes">Bacillus</italic> sp. (<bold>i</bold>), <italic toggle="yes">S. aureus</italic> (<bold>ii</bold>), <italic toggle="yes">Y. enterocolitica</italic> (<bold>iii</bold>) and <italic toggle="yes">E. coli</italic> (<bold>iv</bold>) @ 100 (<bold>A</bold>), 250 (<bold>B</bold>), 500 (<bold>C</bold>) and 1000&#160;&#181;g/ml (<bold>D</bold>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig4_HTML.jpg"/></fig>
</p><p id="Par57">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Antibacterial activity of compounds (I&#8211;VIII) in terms of diameter of Inhibition zone against <italic toggle="yes">Bacillus</italic> Sp.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Compounds</th><th align="left" colspan="7" rowspan="1">Diameter of Inhibition zone (mm) at different concentrations (&#181;g/ml)</th></tr><tr><th align="left" colspan="1" rowspan="1">50</th><th align="left" colspan="1" rowspan="1">100</th><th align="left" colspan="1" rowspan="1">125</th><th align="left" colspan="1" rowspan="1">250</th><th align="left" colspan="1" rowspan="1">500</th><th align="left" colspan="1" rowspan="1">1000</th><th align="left" colspan="1" rowspan="1">Mean</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">I</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">1.00&#8201;&#177;&#8201;0.04</td><td align="left" colspan="1" rowspan="1">6.56&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">9.65&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">2.87<sup>f</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">II</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">1.95&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1">8.56&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">11.11&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">3.61<sup>f</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">III</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">1.72&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">9.54&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">15.85&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">28.64&#8201;&#177;&#8201;0.07</td><td align="left" colspan="1" rowspan="1">32.32&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">14.68<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">IV</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">5.79&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">15.85&#8201;&#177;&#8201;0.22</td><td align="left" colspan="1" rowspan="1">17.75&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">6.59<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">V</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">0.56&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">5.33&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">11.05&#8201;&#177;&#8201;0.14</td><td align="left" colspan="1" rowspan="1">24.77&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1">27.84&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">11.60<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VI</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.56&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">12.85&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">15.65&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1">5.52<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VII</td><td align="left" colspan="1" rowspan="1">1.35&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">7.51&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">14.85&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">23.95&#8201;&#177;&#8201;0.05</td><td align="left" colspan="1" rowspan="1">34.67&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">37.22&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">20.10<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VIII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">2.18&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">9.89&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">19.55&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">21.44&#8201;&#177;&#8201;0.07</td><td align="left" colspan="1" rowspan="1">8.85<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mean</td><td align="left" colspan="1" rowspan="1">0.17<sup>f</sup></td><td align="left" colspan="1" rowspan="1">2.46<sup>e</sup></td><td align="left" colspan="1" rowspan="1">4.01<sup>d</sup></td><td align="left" colspan="1" rowspan="1">9.31<sup>c</sup></td><td align="left" colspan="1" rowspan="1">17.94<sup>b</sup></td><td align="left" colspan="1" rowspan="1">21.72<sup>a</sup></td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin (positive control) (10&#160;&#181;g/ml)</td><td align="left" colspan="6" rowspan="1">44.02&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">44.02</td></tr></tbody></table><table-wrap-foot><p>ND stands for not detected. Data has been expressed as mean&#8201;&#177;&#8201;standard deviation. Mean values with different superscripts in the above table represented significant difference (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) using Two-way ANOVA followed by Tukey-B test.</p></table-wrap-foot></table-wrap>
</p><p id="Par59">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Antibacterial activity of compounds (I&#8211;VIII) in terms of diameter of Inhibition zone against <italic toggle="yes">S. Aureus.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Compounds</th><th align="left" colspan="7" rowspan="1">Diameter of Inhibition zone (mm) at different concentrations (&#181;g/ml)</th></tr><tr><th align="left" colspan="1" rowspan="1">50</th><th align="left" colspan="1" rowspan="1">100</th><th align="left" colspan="1" rowspan="1">125</th><th align="left" colspan="1" rowspan="1">250</th><th align="left" colspan="1" rowspan="1">500</th><th align="left" colspan="1" rowspan="1">1000</th><th align="left" colspan="1" rowspan="1">Mean</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">I</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">5.14&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">7.32&#8201;&#177;&#8201;0.20</td><td align="left" colspan="1" rowspan="1">2.12<sup>f</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">II</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">1.71&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">7.16&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">10.21&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">3.20<sup>ef</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">III</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">6.65&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">15.99&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">25.22&#8201;&#177;&#8201;0.17</td><td align="left" colspan="1" rowspan="1">29.30&#8201;&#177;&#8201;0.05</td><td align="left" colspan="1" rowspan="1">12.87<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">IV</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">5.66&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">13.55&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">15.98&#8201;&#177;&#8201;0.05</td><td align="left" colspan="1" rowspan="1">5.87<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">V</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">3.45&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">13.15&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">22.18&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">25.23&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">10.67<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VI</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">3.50&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">10.85&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">13.57&#8201;&#177;&#8201;0.14</td><td align="left" colspan="1" rowspan="1">4.66<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.10&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">11.85&#8201;&#177;&#8201;0.14</td><td align="left" colspan="1" rowspan="1">20.71&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">29.45&#8201;&#177;&#8201;0.20</td><td align="left" colspan="1" rowspan="1">33.14&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">16.56<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VIII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">8.55&#8201;&#177;&#8201;0.01</td><td align="left" colspan="1" rowspan="1">16.65&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">19.30&#8201;&#177;&#8201;0.17</td><td align="left" colspan="1" rowspan="1">7.42<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mean</td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">0.52<sup>d</sup></td><td align="left" colspan="1" rowspan="1">2.75<sup>d</sup></td><td align="left" colspan="1" rowspan="1">8.66<sup>c</sup></td><td align="left" colspan="1" rowspan="1">16.30<sup>b</sup></td><td align="left" colspan="1" rowspan="1">19.26<sup>a</sup></td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin (positive control) (10&#160;&#181;g/ml)</td><td align="left" colspan="6" rowspan="1">40.55&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">40.55</td></tr></tbody></table><table-wrap-foot><p>ND stands for not detected. Data has been expressed as mean&#8201;&#177;&#8201;standard deviation. Mean values with different superscripts in the above table represented significant difference (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) using Two-way ANOVA followed by Tukey-B test.</p></table-wrap-foot></table-wrap>
</p><p id="Par61">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Antibacterial activity of compounds (I&#8211;VIII) in terms of diameter of Inhibition zone against <italic toggle="yes">Y. Enterocolitica.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Compounds</th><th align="left" colspan="7" rowspan="1">Diameter of Inhibition zone (mm) at different concentrations (&#181;g/ml)</th></tr><tr><th align="left" colspan="1" rowspan="1">50</th><th align="left" colspan="1" rowspan="1">100</th><th align="left" colspan="1" rowspan="1">125</th><th align="left" colspan="1" rowspan="1">250</th><th align="left" colspan="1" rowspan="1">500</th><th align="left" colspan="1" rowspan="1">1000</th><th align="left" colspan="1" rowspan="1">Mean</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">I</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">6.98&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">8.50&#8201;&#177;&#8201;0.21</td><td align="left" colspan="1" rowspan="1">2.58<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">II</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.87&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">5.84&#8201;&#177;&#8201;0.09</td><td align="left" colspan="1" rowspan="1">1.79<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">III</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">2.85&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">13.41&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">24.50&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">27.65&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">11.41<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">IV</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">7.56&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">18.77&#8201;&#177;&#8201;0.07</td><td align="left" colspan="1" rowspan="1">21.65&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">7.99<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">V</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">9.50&#8201;&#177;&#8201;0.20</td><td align="left" colspan="1" rowspan="1">12.69&#8201;&#177;&#8201;0.14</td><td align="left" colspan="1" rowspan="1">3.70<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VI</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">2.50&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">12.97&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">16.08&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">5.27<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">9.55&#8201;&#177;&#8201;0.05</td><td align="left" colspan="1" rowspan="1">20.85&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">22.64&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">8.85<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VIII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">5.84&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">15.85&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">17.69&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">6.57<sup>bc</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mean</td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">0.36<sup>d</sup></td><td align="left" colspan="1" rowspan="1">4.87<sup>c</sup></td><td align="left" colspan="1" rowspan="1">14.30<sup>b</sup></td><td align="left" colspan="1" rowspan="1">17.19<sup>a</sup></td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin (positive control) (10&#160;&#181;g/ml)</td><td align="left" colspan="6" rowspan="1">38.25&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">38.25</td></tr></tbody></table><table-wrap-foot><p>ND stands for not detected. Data has been expressed as mean&#8201;&#177;&#8201;standard deviation. Mean values with different superscripts in the above table represented significant difference (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) using Two-way ANOVA followed by Tukey-B test.</p></table-wrap-foot></table-wrap>
</p><p id="Par63">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Antibacterial activity of compounds (I-VIII) in terms of diameter of Inhibition zone against <italic toggle="yes">E. Coli.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Compounds</th><th align="left" colspan="7" rowspan="1">Diameter of Inhibition zone (mm) at different concentrations (&#181;g/ml)</th></tr><tr><th align="left" colspan="1" rowspan="1">50</th><th align="left" colspan="1" rowspan="1">100</th><th align="left" colspan="1" rowspan="1">125</th><th align="left" colspan="1" rowspan="1">250</th><th align="left" colspan="1" rowspan="1">500</th><th align="left" colspan="1" rowspan="1">1000</th><th align="left" colspan="1" rowspan="1">Mean</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">I</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.21&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">5.64&#8201;&#177;&#8201;0.20</td><td align="left" colspan="1" rowspan="1">1.65<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">II</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">3.11&#8201;&#177;&#8201;0.11</td><td align="left" colspan="1" rowspan="1">4.98&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">1.35<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">III</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">10.44&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">19.88&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">22.51&#8201;&#177;&#8201;0.08</td><td align="left" colspan="1" rowspan="1">8.82<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">IV</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">4.18&#8201;&#177;&#8201;0.16</td><td align="left" colspan="1" rowspan="1">12.08&#8201;&#177;&#8201;0.17</td><td align="left" colspan="1" rowspan="1">15.65&#8201;&#177;&#8201;0.20</td><td align="left" colspan="1" rowspan="1">5.32<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">V</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">5.25&#8201;&#177;&#8201;0.18</td><td align="left" colspan="1" rowspan="1">7.94&#8201;&#177;&#8201;0.12</td><td align="left" colspan="1" rowspan="1">2.19<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VI</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">7.07&#8201;&#177;&#8201;0.03</td><td align="left" colspan="1" rowspan="1">9.48&#8201;&#177;&#8201;0.13</td><td align="left" colspan="1" rowspan="1">2.76<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">8.25&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">15.45&#8201;&#177;&#8201;0.18</td><td align="left" colspan="1" rowspan="1">18.50&#8201;&#177;&#8201;0.10</td><td align="left" colspan="1" rowspan="1">7.05<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">VIII</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">ND</td><td align="left" colspan="1" rowspan="1">9.25&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">12.22&#8201;&#177;&#8201;0.05</td><td align="left" colspan="1" rowspan="1">3.58<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mean</td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">0.00<sup>d</sup></td><td align="left" colspan="1" rowspan="1">2.87<sup>c</sup></td><td align="left" colspan="1" rowspan="1">9.54<sup>b</sup></td><td align="left" colspan="1" rowspan="1">12.12<sup>a</sup></td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin (positive control) (10&#160;&#181;g/ml)</td><td align="left" colspan="6" rowspan="1">32.54&#8201;&#177;&#8201;0.15</td><td align="left" colspan="1" rowspan="1">32.54</td></tr></tbody></table><table-wrap-foot><p>ND stands for not detected. Data has been expressed as mean&#8201;&#177;&#8201;standard deviation. Mean values with different superscripts in the above table represented significant difference (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) using Two-way ANOVA followed by Tukey-B test.</p></table-wrap-foot></table-wrap>
</p><p id="Par65">The enhanced antibacterial activity of esters may be due to their increased lipophilic character as compared to the parent alcohols which enhanced their ability to penetrate the microbial cell membranes. This increased penetration allows them to disrupt cellular processes more effectively, leading to higher antimicrobial efficacy<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. This fact also got support from the work done by Kopecna et al.<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> where esters of various terpene alcohols have been reported as skin penetration enhancers. The greater antibacterial potential of geranyl cinnamate against <italic toggle="yes">E. coli</italic> and <italic toggle="yes">S. aureus</italic> has been reported due to synergistic interaction of its substrates i.e., geraniol and cinnamic acid<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Mathela et al.<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> observed that thymol ester derivatives exhibited enhanced activity against Gram-positive strains. Specifically, 2-isopropyl-5-methylphenyl acetate and 2-isopropyl-5-methylphenyl isobutyrate showed greater effectiveness than thymol itself against <italic toggle="yes">S. mutans</italic> (MIC&#8201;=&#8201;11.7 and 93.7 &#181;M), <italic toggle="yes">B. subtilis</italic> (MIC&#8201;=&#8201;11.7 and 46.8 &#181;M), and <italic toggle="yes">S. epidermidis</italic> (MIC&#8201;=&#8201;11.7 and 46.8 &#181;M). Our results were further supported by da Silva et al.<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> who synthesized the eugenol ester derivative and reported the greater antibacterial activity of eugenol ester (MIC&#8201;=&#8201;500&#160;&#181;g/mL) in comparison to the parent compound eugenol (MIC&#8201;=&#8201;1000&#160;&#181;g/mL) against <italic toggle="yes">E. coli.</italic> Moreover, various ester derivatives of polyether antibiotics- salinomycin and blasticidin (peptidyl nucleoside) have been reported to have enhanced antibacterial activity as compared to their parent compounds<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. Lather et al.<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> also reported the potent antimicrobial potential of p-nitro aniline derivative of naringenin against <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> having pMIC&#8201;=&#8201;1.49 &#181;M/mL.</p></sec><sec id="Sec25"><title>Cell constituents release study</title><p id="Par66">The release of bacterial cell constituents indicated irreversible damage to cell membranes caused by the treatment with test components. In comparison to the control, all the test samples revealed a significant enhancement in the release of cellular contents in all the tested bacteria as represented by the rise in OD values (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>). The derivatives resulted in greater cellular content release as compared to the parent compounds. Compound VII caused the highest release of cellular contents in Gram-positive strains i.e., <italic toggle="yes">Bacillus</italic> sp. with a maximum OD value (0.885&#8201;&#177;&#8201;0.11) and <italic toggle="yes">S. aureus</italic> (OD; 0.789&#8201;&#177;&#8201;0.15), whereas, compound III caused the highest release of cellular contents in Gram-negative strains i.e., <italic toggle="yes">Y. enterocolitica</italic> (OD; 0.715&#8201;&#177;&#8201;0.01) and <italic toggle="yes">E. coli</italic> (OD; 0.645&#8201;&#177;&#8201;0.11). However, among the parent compounds (I and II), compound I caused greater cell constituent release in Gram-negative bacteria and compound II caused greater cell constituent release in Gram-positive bacteria.</p><p>
<fig id="Fig5" position="float" orientation="portrait"><label>Fig.&#160;5</label><caption><p>Effect of isolated major compounds and their derivatives on release of cell components in tested bacterial strains. Values with different superscripts represent the significant difference at <italic toggle="yes">p</italic> &lt; 0.05 using Tukey-B test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig5_HTML.jpg"/></fig>
</p><p id="Par68">Our results also got support from the study of Song et al.<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> where ferulic acid esters revealed greater cell content release (protein and nucleic acid) from <italic toggle="yes">Pseudomonas aeruginosa</italic> as shown by membrane hyperpolarization than ferulic acid. In another study, Shi et al.<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> reported that alkyl ferulate esters significantly compromised <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> cytomembranes resulting in the leakage of cellular constituents from <italic toggle="yes">E. coli</italic> such as nucleotides, proteins, potassium ions, and &#946;-galactosidase.</p><p id="Par69">Regarding the bacterial cell constituents release studies of major compounds (&#945;-terpineol and 4-carvomenthenol), it has been reported that &#945;-terpineol compromised the integrity and permeability of bacterial cell membranes resulting in cell lysis through the dissolution of the cell wall<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Li et al.<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> studied the mode of action of &#945;-terpineol on <italic toggle="yes">E. coli</italic> and suggested direct alterations in the bacterial cell membrane structure causing unequal division, plasmolysis and loss of cytoplasm.</p></sec><sec id="Sec26"><title>Synergistic interaction of compounds (I), (II), (III) and (VII) with standard antibiotic</title><p id="Par70">The synergistic effect resulting from the interaction of synthetic antibiotics and plant based natural compounds acts as a complementary strategy to restrict the dosage of synthetic antibiotics thereby reducing their adverse effects<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The reason behind the synergistic action can be explained by the fact that when plant extracts are combined with synthetic antibiotics, they tend to lower their MIC values due to the presence of a mixture of bioactive components in these extracts that enhance the antimicrobial efficacy of antibiotics<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. The synergistic interaction of isolated major compounds (I) and (II) and the most effective derivatives i.e., their ester (III) and (VII) was studied with streptomycin. The results revealed that the compound (VII) (at 1/8 of MIC against <italic toggle="yes">Bacillus</italic> sp. and <italic toggle="yes">S. aureus</italic>, and 1/4 of MIC against <italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">E. coli</italic>) showed a synergistic interaction with streptomycin (at 1/32 of MIC against <italic toggle="yes">Bacillus</italic> sp., 1/16 of MIC against <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Y. enterocolitica</italic>, and <italic toggle="yes">E. coli</italic>) having FICI&#8201;&lt;&#8201;0.5 against all the tested bacteria (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>). Compound (III) (at 1/8, 1/4 and 1/4 of MIC) showed a synergistic effect with streptomycin (at 1/16, 1/16 and 1/8 of MIC) against <italic toggle="yes">Bacillus</italic> sp., <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Y. enterocolitica</italic> with FICI of 0.188, 0.312 and 0.375 respectively, whereas it exhibited additive effect with streptomycin against <italic toggle="yes">E. coli</italic> with FICI&#8201;=&#8201;0.625. The pure compound (II) (at 1/2 of MIC) in combination with streptomycin (at 1/16, 1/8 and 1/4 of MIC) revealed the additive effect against <italic toggle="yes">Bacillus</italic> sp., <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Y. enterocolitica</italic> with FICI of 0.562, 0.625 and 0.750 respectively, whereas their combination showed indifferent behaviour against <italic toggle="yes">E. coli</italic> with FICI value 1.50. On the other hand, pure compound (I) in combination with streptomycin showed an additive effect against <italic toggle="yes">Bacillus</italic> sp. and <italic toggle="yes">S. aureus</italic> having FICI of 0.750 and 1.00 respectively. The pure compounds exhibited indifferent interaction against <italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">E. coli</italic> with FICI of 1.50 and 2.00 respectively.</p><p id="Par71">
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Synergistic interaction of isolated major compounds and their ester derivatives in combination with streptomycin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Bacteria</th><th align="left" colspan="1" rowspan="1">Related indexes</th><th align="left" colspan="1" rowspan="1">Compound (I)</th><th align="left" colspan="1" rowspan="1">SMN</th><th align="left" colspan="1" rowspan="1">Compound (II)</th><th align="left" colspan="1" rowspan="1">SMN</th><th align="left" colspan="1" rowspan="1">Compound (III)</th><th align="left" colspan="1" rowspan="1">SMN</th><th align="left" colspan="1" rowspan="1">Compound (VII)</th><th align="left" colspan="1" rowspan="1">SMN</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1"><italic toggle="yes">Bacillus</italic> sp.</td><td align="left" colspan="1" rowspan="1">MIC<sub>a</sub></td><td align="left" colspan="1" rowspan="1">245.00</td><td align="left" colspan="1" rowspan="1">6.00</td><td align="left" colspan="1" rowspan="1">220.00</td><td align="left" colspan="1" rowspan="1">6.00</td><td align="left" colspan="1" rowspan="1">75.00</td><td align="left" colspan="1" rowspan="1">6.00</td><td align="left" colspan="1" rowspan="1">40.00</td><td align="left" colspan="1" rowspan="1">6.00</td></tr><tr><td align="left" colspan="1" rowspan="1">MIC<sub>c</sub></td><td align="left" colspan="1" rowspan="1"><p>122.50</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>1.50</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>110.00</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>0.37</p><p>(MIC/16)</p></td><td align="left" colspan="1" rowspan="1"><p>9.38</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>0.37</p><p>(MIC/16)</p></td><td align="left" colspan="1" rowspan="1"><p>5.00</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>0.19</p><p>(MIC/32)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">FIC</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.06</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.06</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">FICI</td><td align="left" colspan="1" rowspan="1">0.75 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.56 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.18 (S)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.15 (S)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" rowspan="4" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="left" colspan="1" rowspan="1">MIC<sub>a</sub></td><td align="left" colspan="1" rowspan="1">260.00</td><td align="left" colspan="1" rowspan="1">7.00</td><td align="left" colspan="1" rowspan="1">235.00</td><td align="left" colspan="1" rowspan="1">7.00</td><td align="left" colspan="1" rowspan="1">105.00</td><td align="left" colspan="1" rowspan="1">7.00</td><td align="left" colspan="1" rowspan="1">65.00</td><td align="left" colspan="1" rowspan="1">7.00</td></tr><tr><td align="left" colspan="1" rowspan="1">MIC<sub>c</sub></td><td align="left" colspan="1" rowspan="1"><p>130.00</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>3.50</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>117.50</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>0.87</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>26.25</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>0.44</p><p>(MIC/16)</p></td><td align="left" colspan="1" rowspan="1"><p>8.12</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>0.44</p><p>(MIC/16)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">FIC</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.06</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.06</td></tr><tr><td align="left" colspan="1" rowspan="1">FICI</td><td align="left" colspan="1" rowspan="1">1.00 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.62 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.31 (S)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.18 (S)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" rowspan="4" colspan="1">
<italic toggle="yes">Y. enterocolitica</italic>
</td><td align="left" colspan="1" rowspan="1">MIC<sub>a</sub></td><td align="left" colspan="1" rowspan="1">310.00</td><td align="left" colspan="1" rowspan="1">8.00</td><td align="left" colspan="1" rowspan="1">340.00</td><td align="left" colspan="1" rowspan="1">8.00</td><td align="left" colspan="1" rowspan="1">120.00</td><td align="left" colspan="1" rowspan="1">8.00</td><td align="left" colspan="1" rowspan="1">145.00</td><td align="left" colspan="1" rowspan="1">8.00</td></tr><tr><td align="left" colspan="1" rowspan="1">MIC<sub>c</sub></td><td align="left" colspan="1" rowspan="1"><p>310</p><p>(MIC)</p></td><td align="left" colspan="1" rowspan="1"><p>4.00</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>170.00</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>2.00</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>30.00</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>1.00</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>36.25</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>0.50</p><p>(MIC/16)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">FIC</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.06</td></tr><tr><td align="left" colspan="1" rowspan="1">FICI</td><td align="left" colspan="1" rowspan="1">1.50 (I)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.75 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.37 (S)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.31 (S)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" rowspan="4" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" colspan="1" rowspan="1">MIC<sub>a</sub></td><td align="left" colspan="1" rowspan="1">365.00</td><td align="left" colspan="1" rowspan="1">8.70</td><td align="left" colspan="1" rowspan="1">380.00</td><td align="left" colspan="1" rowspan="1">8.70</td><td align="left" colspan="1" rowspan="1">155.00</td><td align="left" colspan="1" rowspan="1">8.70</td><td align="left" colspan="1" rowspan="1">170.00</td><td align="left" colspan="1" rowspan="1">8.70</td></tr><tr><td align="left" colspan="1" rowspan="1">MIC<sub>c</sub></td><td align="left" colspan="1" rowspan="1"><p>365.00</p><p>(MIC)</p></td><td align="left" colspan="1" rowspan="1"><p>8.70</p><p>(MIC)</p></td><td align="left" colspan="1" rowspan="1"><p>380.00</p><p>(MIC)</p></td><td align="left" colspan="1" rowspan="1"><p>4.35</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>77.50</p><p>(MIC/2)</p></td><td align="left" colspan="1" rowspan="1"><p>1.09</p><p>(MIC/8)</p></td><td align="left" colspan="1" rowspan="1"><p>42.50</p><p>(MIC/4)</p></td><td align="left" colspan="1" rowspan="1"><p>0.54</p><p>(MIC/16)</p></td></tr><tr><td align="left" colspan="1" rowspan="1">FIC</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.50</td><td align="left" colspan="1" rowspan="1">0.12</td><td align="left" colspan="1" rowspan="1">0.25</td><td align="left" colspan="1" rowspan="1">0.06</td></tr><tr><td align="left" colspan="1" rowspan="1">FICI</td><td align="left" colspan="1" rowspan="1">2.00 (I)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.50 (I)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.62 (A)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.31 (S)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>MIC<sub>a</sub>= MIC of test component alone, MIC<sub>c</sub>= MIC of sample in combination with antibiotic streptomycin (SMN). Results are expressed as synergy (S, FICI&#8201;&#8804;&#8201;0.5), Additive (A, 0.5&#8201;&lt;&#8201;FICI&#8201;&#8804;&#8201;1), Indifferent (I, 1&#8201;&#8804;&#8201;FICI&#8201;&#8804;&#8201;4) or antagonism (AN, FICI&#8201;&gt;&#8201;4).</p></table-wrap-foot></table-wrap>
</p><p id="Par73">In support of our study, numerous researchers have reported the synergistic potential of &#945;-terpineol and 4-carvomenthenol with either standard antibiotics or any other natural bioactive metabolite. Johansen et al.<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> revealed the synergistic interaction between 4-carvomenthenol (concentration 0.039-2.5%) and &#945;-terpineol (concentration 0.001-2.5%) against <italic toggle="yes">S. aureus</italic>, MRSA, <italic toggle="yes">E. coli</italic> and <italic toggle="yes">P. aeruginosa</italic> with FICI&#8201;&#8804;&#8201;0.5 against all the tested bacterial strains. Cordeiro et al.<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> revealed the synergistic effect of 4-carvomenthenol with cefazolin, oxacillin and meropenem with FICI values to be 0.50, 0.32 and 0.50 respectively against <italic toggle="yes">S. aureus</italic> but synergy was not noted with vancomycin and gentamicin.</p></sec><sec id="Sec100"><title>Antibiofilm activity of the most effective ester derivatives (III and VII) alone and in combination with standard antibiotic</title><p id="Par75">Biofilm is the collective structure formed by bacterial colonies within a self-produced matrix. This matrix offers protection to the bacteria against challenging environmental conditions. It is one of the key factors in extending bacterial infection by shielding the bacteria from the action of antibiotics<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. As the ester derivatives i.e., compound (VII) and (III) exhibited maximum antibacterial potential among all the test components and synergistic/additive interaction with standard antibiotic (streptomycin), thus they were further examined for their antibiofilm potential alone and in combination with streptomycin. The results were represented in terms of Specific biofilm formation (SBF) values.</p><p id="Par76">In has been observed that the compound (VII) and (III) in combination with streptomycin showed a significant decrease in biofilm formation in all the tested bacteria as indicated by no ring formation/distorted ring in the crystal violet assay (Figs.&#160;<xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>). The compound (VII) when tested alone @ MIC revealed intermediate biofilm formation against <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Bacillus</italic> sp. (SBF values 1.81 and 1.11 respectively) and strong biofilm formation against <italic toggle="yes">Y. enterocolitica</italic> and <italic toggle="yes">S. aureus</italic> (SBF values 2.22 and 2.35 respectively). Whereas, compound (III) @ MIC revealed intermediate biofilm formation against <italic toggle="yes">E. coli</italic> and <italic toggle="yes">S. aureus</italic> (SBF values 1.88 and 1.58 respectively) and strong biofilm formation against <italic toggle="yes">Bacillus</italic> sp. and <italic toggle="yes">Y. enterocolitica</italic> (SBF value 2.13 and 2.54 respectively). However, the combination of compound (VII) @ MIC/8 with streptomycin @ MIC/32 revealed weak biofilm formation with SBF value of 0.68 against <italic toggle="yes">Bacillus</italic> sp. Also, weak biofilm formation was observed by the combination of compound (VII) @ MIC/4 with streptomycin @ MIC/16 with SBF value 0.98 against <italic toggle="yes">E. coli</italic>. Whereas, intermediate biofilm formation was observed by the combination of compound (VII) with streptomycin with SBF values of 1.05 and 1.37 against <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Y. enterocolitica.</italic> On the other hand, compound (III) @ MIC/8 in combination with streptomycin @ MIC/16 showed intermediate biofilm formation against <italic toggle="yes">Bacillus</italic> sp. (SBF&#8201;=&#8201;1.25) and weak biofilm was formed against all other test bacteria at different combinations (Table&#160;<xref rid="Tab6" ref-type="table">6</xref>). Hence, it can be concluded that the combination of compound (VII) and (III) with streptomycin led to a significant decrease in the biofilm formation (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05).</p><p>
<fig id="Fig6" position="float" orientation="portrait"><label>Fig.&#160;6</label><caption><p>Ring formation using crystal violet assay in control (<bold>A</bold>), compound (VII) alone @MIC (<bold>B</bold>), compound (VII) in combination with standard (<bold>C</bold>) and standard alone (<bold>D</bold>) against <italic toggle="yes">Bacillus</italic> sp. (i), <italic toggle="yes">S. aureus</italic> (ii), <italic toggle="yes">Y. enterocolitica</italic> (iii), <italic toggle="yes">E. coli</italic> (iv).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO6" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig6_HTML.jpg"/></fig>
</p><p>
<fig id="Fig7" position="float" orientation="portrait"><label>Fig.&#160;7</label><caption><p>Ring formation using crystal violet assay in control (<bold>A</bold>), compound (IV) alone @MIC (<bold>B</bold>), in compound (III) in combination with standard (<bold>C</bold>) and standard alone (<bold>D</bold>) against <italic toggle="yes">Bacillus</italic> sp.(i), <italic toggle="yes">S. aureus</italic> (ii), <italic toggle="yes">E. coli</italic> (iii), <italic toggle="yes">Y. enterocolitica</italic> (iv).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO7" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig7_HTML.jpg"/></fig>
</p><p id="Par79">
<table-wrap id="Tab6" position="float" orientation="portrait"><label>Table 6</label><caption><p>Antibiofilm potential of compound (VII) and (III) alone and in combination with streptomycin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Test bacteria</th><th align="left" colspan="6" rowspan="1">SBF values</th></tr><tr><th align="left" colspan="1" rowspan="1">Compound (VII) (@ MIC values)</th><th align="left" colspan="1" rowspan="1">Compound (VII) + Streptomycin</th><th align="left" colspan="1" rowspan="1">Compound (III) (@ MIC values)</th><th align="left" colspan="1" rowspan="1">Compound (III) + Streptomycin</th><th align="left" colspan="1" rowspan="1">Control</th><th align="left" colspan="1" rowspan="1">Streptomycin</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">E. coli</italic>
</td><td align="left" colspan="1" rowspan="1">1.81 (I)</td><td align="left" colspan="1" rowspan="1">0.98 (W)</td><td align="left" colspan="1" rowspan="1">1.88 (I)</td><td align="left" colspan="1" rowspan="1">0.99 (W)</td><td align="left" colspan="1" rowspan="1">2.28 (S)</td><td align="left" colspan="1" rowspan="1">0.85 (W)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Y. enterocolitica</italic>
</td><td align="left" colspan="1" rowspan="1">2.22 (S)</td><td align="left" colspan="1" rowspan="1">1.37 (I)</td><td align="left" colspan="1" rowspan="1">2.54 (S)</td><td align="left" colspan="1" rowspan="1">0.94 (W)</td><td align="left" colspan="1" rowspan="1">3.14 (S)</td><td align="left" colspan="1" rowspan="1">0.77 (W)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Bacillus</italic> sp.</td><td align="left" colspan="1" rowspan="1">1.11 (I)</td><td align="left" colspan="1" rowspan="1">0.68 (W)</td><td align="left" colspan="1" rowspan="1">2.13 (S)</td><td align="left" colspan="1" rowspan="1">1.25 (I)</td><td align="left" colspan="1" rowspan="1">2.85 (S)</td><td align="left" colspan="1" rowspan="1">0.54 (W)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="left" colspan="1" rowspan="1">2.35 (S)</td><td align="left" colspan="1" rowspan="1">1.05 (I)</td><td align="left" colspan="1" rowspan="1">1.58 (I)</td><td align="left" colspan="1" rowspan="1">0.91 (W)</td><td align="left" colspan="1" rowspan="1">3.05 (S)</td><td align="left" colspan="1" rowspan="1">0.65 (W)</td></tr></tbody></table></table-wrap>
</p><p id="Par80">In favour of our results, Song et al.<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> reported the antibiofilm potential of alkyl ferulic acid esters against <italic toggle="yes">P. aeruginosa</italic> with hexyl ferulate revealing the maximum potential inhibiting 78% followed by propyl ferulate inhibiting 43% of biofilm formation. It resulted in wrinkled and rough cell surface followed by aggregation, adhesion and rupturing of cell. Cordeiro et al.<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> revealed the strong antibiofilm potential of 4-carvomenthenol against <italic toggle="yes">S. aureus</italic> inhibiting more than 80% of biofilm formation at 0.5MIC and 90% inhibition was observed at a concentration of 2MIC and 4MIC. Moreover, numerous studies have shown that terpinen-4-ol exhibited promising efficacy in combating biofilms produced by oral pathogens such as <italic toggle="yes">Porphyromonas gingivalis</italic>, <italic toggle="yes">Fusobacterium nucleatum</italic>, <italic toggle="yes">Streptococcus mutans</italic>, and <italic toggle="yes">Lactobacillus acidophilus</italic><sup><xref ref-type="bibr" rid="CR64">64</xref>&#8211;<xref ref-type="bibr" rid="CR66">66</xref></sup>.</p><sec id="Sec27"><title>Molecular docking studies</title><p id="Par81">Molecular docking studies are used to identify effective drug candidates by observing how a drug-like molecule will interact with the target protein thus aiding in understanding the molecular mechanism<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. DNA gyrase (type II topoisomerase), the key bacterial enzyme is involved in bacterial DNA replication, transcription and in catalyzing its negative supercoiling. Thus, it serves as an important target for antibacterial drugs. Another key target enzyme is transpeptidase, penicillin-binding protein 2a which facilitates the nucleophilic carbonyl substitution reaction and is essential for cross-linking peptidoglycan in the cell wall of bacteria<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Hence in the present study, molecular docking of both the ester derivatives being the most effective was carried out to predict their interaction with the binding sites of DNA gyrase (PDB: 1KZN) and transpeptidase, penicillin-binding protein 2a (PBP2a, PDB: 1MWT).</p><p id="Par82">Both the ester derivatives displayed favorable binding affinities with the targeted proteins ranged from &#8722;&#8201;6.56 to &#8722;&#8201;4.31&#160;kcal/mol (Table&#160;<xref rid="Tab7" ref-type="table">7</xref>). However, they exhibited more binding affinity with DNA gyrase than transpeptidase, penicillin-binding protein 2a. The docking scores and various interactions involving hydrogen bonding, hydrophobic and Van der Waals interactions are represented in Table&#160;<xref rid="Tab7" ref-type="table">7</xref>. It has been found that after streptomycin (&#8211;6.56&#160;kcal/mol), &#945;-terpineol ester showed a greater binding affinity (-6.11&#160;kcal/mol) than 4-carvomenthenol ester (-5.42&#160;kcal/mol) with DNA gyrase (Fig.&#160;<xref rid="Fig8" ref-type="fig">8</xref>). &#945;-Terpineol ester formed one hydrogen bond with Val167, one hydrophobic interaction with Ile78 and twelve Van der Waals interactions with Ala47, Asp73, Asn46, Thr165, Val43, Val71, Met166, Met91, Val120, Gln72, Gly77, Glu50 amino acid residues. 4-Carvomenthenol ester showed hydrophobic interactions with four amino acid residues (Ile78, Ala47, Val43, Val167) with zero hydrogen bonding and three Van der Waals interactions with Asn46, Val71, Glu50 residues.</p><p>
<fig id="Fig8" position="float" orientation="portrait"><label>Fig.&#160;8</label><caption><p>Representation of the binding of three compounds (Streptomycin, &#945;-terpineol ester and 4-carvomenthenol ester) to DNA gyrase (PDB: 1KZN). Grey cartoon on the top left represents the overlays of the docked compounds and the cognate ligand bound to DNA Gyrase, where the docked compounds are color coded. Each rectangular box depicts the binding pockets constituted by amino acids, represented by circles that indicate their chain ID and residue number. The docked compounds are shown in sticks and docking scores (kcal mol<sup>&#8211;1</sup>) are provided for each complex.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO8" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig8_HTML.jpg"/></fig>
</p><p id="Par84">
<table-wrap id="Tab7" position="float" orientation="portrait"><label>Table 7</label><caption><p>The binding affinity of DNA gyrase and transpeptidase with ester derivatives and streptomycin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="5" rowspan="1">DNA gyrase (PDB: 1KZN)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Compound</td><td align="left" colspan="1" rowspan="1">Binding affinity (kcal/mol)</td><td align="left" colspan="1" rowspan="1">Residues involved in hydrogen bonding with ligands</td><td align="left" colspan="1" rowspan="1">Residues involved in hydrophobic interactions with ligands</td><td align="left" colspan="1" rowspan="1">Residues involved in Van der Waals interaction with ligands</td></tr><tr><td align="left" colspan="1" rowspan="1">&#945;-terpineol ester</td><td align="left" colspan="1" rowspan="1">-6.11</td><td align="left" colspan="1" rowspan="1">Val167</td><td align="left" colspan="1" rowspan="1">Ile78</td><td align="left" colspan="1" rowspan="1">Ala47, Asp73, Asn46, Thr165, Val43, Val71, Met166, Met91, Val120, Gln72, Gly77, Glu50</td></tr><tr><td align="left" colspan="1" rowspan="1">4-carvomenthenol ester</td><td align="left" colspan="1" rowspan="1">-5.42</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">Ile78, Ala47, Val43, Val167</td><td align="left" colspan="1" rowspan="1">Asn46, Val71, Glu50</td></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin</td><td align="left" colspan="1" rowspan="1">-6.56</td><td align="left" colspan="1" rowspan="1">Arg76, Asn46, Val71, Asp73, Thr165</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">Glu50, Arg136, Gly77, Gln72, Val43, Val167, Met166</td></tr><tr><td align="left" colspan="5" rowspan="1">Transpeptidase, penicillin-binding protein 2a (PBP2a, PDB: 1MWT)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#945;-terpineol ester</td><td align="left" colspan="1" rowspan="1">-4.82</td><td align="left" colspan="1" rowspan="1">Lys215</td><td align="left" colspan="1" rowspan="1">Val217, Pro370, Lys218, Lys219, Tyr369</td><td align="left" colspan="1" rowspan="1">Leu224, Leu190, Glu379, Thr216, Tyr373, Asp367</td></tr><tr><td align="left" colspan="1" rowspan="1">4-carvomenthenol ester</td><td align="left" colspan="1" rowspan="1">-4.31</td><td align="left" colspan="1" rowspan="1">Lys218, Lys219</td><td align="left" colspan="1" rowspan="1">Val217, Pro370, Tyr373</td><td align="left" colspan="1" rowspan="1">Lys215, Asp367, Thr216, Tyr369, Asp221, Leu224</td></tr><tr><td align="left" colspan="1" rowspan="1">Streptomycin</td><td align="left" colspan="1" rowspan="1">-4.39</td><td align="left" colspan="1" rowspan="1">Ser240, Met372, Tyr373, Glu170, Thr238</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">Gly374, Arg241, Glu239</td></tr></tbody></table></table-wrap>
</p><p id="Par85">In the case of transpeptidase, penicillin-binding protein 2a (PBP2a, PDB: 1MWT), &#945;-terpineol ester showed the maximum binding affinity (-4.82&#160;kcal/mol) followed by streptomycin (-4.39&#160;kcal/mol) and 4-carvomenthenol ester (-4.31&#160;kcal/mol) (Fig.&#160;<xref rid="Fig9" ref-type="fig">9</xref>). &#945;-Terpineol ester formed one hydrogen bond with Lys215, five hydrophobic interactions with Val217, Pro370, Lys218, Lys219, Tyr369 residues and six Van der Waals interactions with Leu224, Leu190, Glu379, Thr216, Tyr373, Asp367. 4-Carvomenthenol ester formed two hydrogen bonds with Lys218, Lys219 residues, three hydrophobic interactions with Val217, Pro370, Tyr373 residues and six Van der Waals interactions with Lys215, Asp367, Thr216, Tyr369, Asp221, Leu224 residues. For validation of the adopted docking protocol, the cognate ligands, clorobiocin and penicillin G, were re-docked into their respective target enzymes - DNA gyrase and PBP2a respectively (Fig.&#160;<xref rid="Fig10" ref-type="fig">10</xref>). In both cases, the predicted binding pocket was observed to be similar to the original pocket (Fig.&#160;<xref rid="Fig10" ref-type="fig">10</xref>). Moreover, the superposition of Autodock-generated ligand conformations onto their receptive original crystal structure conformations resulted in reasonable agreement. All these observations as well as RMSD values confirmed the suitability of our docking protocol to computationally analyse DNA gyrase and PBP2a enzymes. Our results were in consonance to Dubar et al.<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> who reported the ciprofloxacin ester derivatives as potent DNA gyrase inhibitors in docking studies. Hossen et al.<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> also revealed very good binding affinity of geranyl acetate with DNA gyrase and transpeptidase.</p><p>
<fig id="Fig9" position="float" orientation="portrait"><label>Fig.&#160;9</label><caption><p>Representation of the binding of three compounds (Streptomycin, &#945;-terpineol ester and 4-carvomenthenol) to the penicillin-binding protein 2a (PBP2a, PDB: 1MWT). Red cartoon on the top represents the overlays of the docked compounds and the cognate ligand bound to PBP2a, where docked compounds are color coded. Each rectangular box depicts the binding pockets constituted by amino acids, represented by circles that indicate their chain ID and residue number. The docked compounds are shown in sticks and docking scores (kcal mol<sup>&#8211;1</sup>) are provided for each complex.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO9" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig9_HTML.jpg"/></fig>
</p><p>
<fig id="Fig10" position="float" orientation="portrait"><label>Fig.&#160;10</label><caption><p>(<bold>A</bold>) The original and docked poses of the cognate ligand (clorobiocin) bound to DNA gyrase (grey cartoon) are represented by black and yellow sticks respectively, with their superpositions shown at the bottom. (<bold>B</bold>) The original and docked poses of the cognate ligand (penicillin G) bound to PBP2a (red cartoon), are represented by black and cyan sticks respectively, with their superposition shown at the bottom. RMSD values are also provided.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO10" position="float" orientation="portrait" xlink:href="41598_2025_3152_Fig10_HTML.jpg"/></fig>
</p></sec><sec id="Sec28"><title>Physiochemical properties</title><p id="Par88">The term &#8216;physicochemical&#8217; refers to the &#8216;drug-likeness&#8217; of a molecule, which influences its ability to function as an oral drug in terms of bioavailability. This is a crucial phase in the drug development, following discovery and involves comprehensive studies on the drug&#8217;s formulation, pharmacokinetics, stability, toxicity, and metabolism<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The difference between drug-like and non-drug-like characteristics of molecules in the early stages of drug development is determined by specific physicochemical properties assessed using Lipinski&#8217;s Rule of Five. It includes different ranges for various physicochemical properties that determine the molecule&#8217;s potential for oral bioavailability<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p><p id="Par89">Both the ester derivatives exhibited all the physiochemical properties within the required range (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>). As both the ester derivatives are structural isomers of each other, most of the physiochemical properties have the same values. The drug molecule&#8217;s ability to pass through the cell membrane has been influenced by factors like molecular weight and topological polar surface area (TPSA). In this study, the molecular weight of both compounds fell within the acceptable range (100&#8211;600 Da), and the TPSA of both compounds was within the desired range (0&#8211;140), suggesting their potential for in vivo permeability. Furthermore, the ability of a drug molecule to traverse the cell&#8217;s bilayer membrane is influenced by the number of hydrogen bond acceptors (nHA, ideally&#8201;&#8804;&#8201;10) and donors (nHD, ideally&#8201;&#8804;&#8201;5). Here, both the compounds showed acceptable limits of nHA and nHD (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>). Another important parameter is LogP, whose value lower than 5 is considered favourable for optimal absorption rates. It defines lipophilicity in terms of the logarithm of the distribution coefficient between organic and aqueous phases<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. Here, both the ester derivatives showed a desirable value of LogP i.e. &lt;5 (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>).</p><p id="Par90">
<table-wrap id="Tab8" position="float" orientation="portrait"><label>Table 8</label><caption><p>Physiochemical properties of &#945;-terpineol ester and 4-carvomenthenol ester.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">S. No.</th><th align="left" rowspan="2" colspan="1">Drug-likeness properties</th><th align="left" colspan="2" rowspan="1">Compounds</th></tr><tr><th align="left" colspan="1" rowspan="1">&#945;-terpineol ester</th><th align="left" colspan="1" rowspan="1">4-carvomenthenol ester</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1.</td><td align="left" colspan="1" rowspan="1">Molecular weight (100-600 Daltons)</td><td align="left" colspan="1" rowspan="1">196.15</td><td align="left" colspan="1" rowspan="1">196.15</td></tr><tr><td align="left" colspan="1" rowspan="1">2.</td><td align="left" colspan="1" rowspan="1">nRing</td><td align="left" colspan="1" rowspan="1">1.0</td><td align="left" colspan="1" rowspan="1">1.0</td></tr><tr><td align="left" colspan="1" rowspan="1">3.</td><td align="left" colspan="1" rowspan="1">nHet (1-15)</td><td align="left" colspan="1" rowspan="1">2.0</td><td align="left" colspan="1" rowspan="1">2.0</td></tr><tr><td align="left" colspan="1" rowspan="1">4.</td><td align="left" colspan="1" rowspan="1">fChar (-4-4)</td><td align="left" colspan="1" rowspan="1">0.0</td><td align="left" colspan="1" rowspan="1">0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">5.</td><td align="left" colspan="1" rowspan="1">MaxRing</td><td align="left" colspan="1" rowspan="1">6.0</td><td align="left" colspan="1" rowspan="1">6.0</td></tr><tr><td align="left" colspan="1" rowspan="1">6.</td><td align="left" colspan="1" rowspan="1">nRig (0-30)</td><td align="left" colspan="1" rowspan="1">7.0</td><td align="left" colspan="1" rowspan="1">7.0</td></tr><tr><td align="left" colspan="1" rowspan="1">7.</td><td align="left" colspan="1" rowspan="1">nHA (&#8804;10)</td><td align="left" colspan="1" rowspan="1">2.0</td><td align="left" colspan="1" rowspan="1">2.0</td></tr><tr><td align="left" colspan="1" rowspan="1">8.</td><td align="left" colspan="1" rowspan="1">nHD (&#8804;5)</td><td align="left" colspan="1" rowspan="1">0.0</td><td align="left" colspan="1" rowspan="1">0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">9.</td><td align="left" colspan="1" rowspan="1">nRot (0-11)</td><td align="left" colspan="1" rowspan="1">3.0</td><td align="left" colspan="1" rowspan="1">3.0</td></tr><tr><td align="left" colspan="1" rowspan="1">10.</td><td align="left" colspan="1" rowspan="1">TPSA (0-140 &#197;)</td><td align="left" colspan="1" rowspan="1">26.3</td><td align="left" colspan="1" rowspan="1">26.3</td></tr><tr><td align="left" colspan="1" rowspan="1">11.</td><td align="left" colspan="1" rowspan="1">LogS (-4&#8211;0.5&#160;mol/L)</td><td align="left" colspan="1" rowspan="1">-2.88</td><td align="left" colspan="1" rowspan="1">-2.80</td></tr><tr><td align="left" colspan="1" rowspan="1">12.</td><td align="left" colspan="1" rowspan="1">LogP (&lt;5&#160;mol/L)</td><td align="left" colspan="1" rowspan="1">3.34</td><td align="left" colspan="1" rowspan="1">3.13</td></tr><tr><td align="left" colspan="1" rowspan="1">13.</td><td align="left" colspan="1" rowspan="1">LogD (1&#8211;3&#160;mol/L)</td><td align="left" colspan="1" rowspan="1">2.99</td><td align="left" colspan="1" rowspan="1">2.77</td></tr></tbody></table><table-wrap-foot><p>Number of heteroatoms (nHet), formal charge (fChar), number of rigid bonds (nRig), number of hydrogen bond acceptors (nHA), number of hydrogen bond donors (nHD), number of rotatable bonds (nRot), topological polar surface area (TPSA), drug solubility (LogS), Distribution coefficient (LogD), lipophilicity (LogP).</p></table-wrap-foot></table-wrap>
</p><p id="Par92">Other than Lipinski parameters, nRot i.e., the number of rotatable bonds indicated the potential of drug molecules for oral bioavailability and its value should range between 0 and 11. In this study, both the ester derivatives have 3 rotatable bonds thus representing their strong oral bioavailability potential. However, the presence of an excessive number of rigid bonds (nRig) (optimal 0&#8211;30) can increase molecular complexity, which may negatively impact the oral bioavailability of a substance. Here, both the derivatives have an acceptable number of rigid bonds (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>).</p><p id="Par93">Both the ester derivatives possessed zero formal charge (fChar, optimal &#8722;&#8201;4 to 4) which means that the enzymes responsible for drug metabolism can effectively interact with charged sites, potentially altering the normal distribution of drug molecules within the body. Also, a higher number of heteroatoms (nHet) suggested enhanced reactivity and a greater potential for particular type of interaction, with the optimal range between 1 and 15. Both the compounds in this study displayed nHet values within this limit (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>). Additionally, the LogS value indicates drug solubility, with lower values being preferred. Both the ester derivatives exhibited LogS value within the range of &#8722;&#8201;4 to 0.5 log mol/L. Distribution coefficient (LogD, optimal 1&#8211;3) influence the drug permeability by affecting the lipophilicity of ionizable compounds. Here, both the compounds also exhibited permissible value for LogD (Table&#160;<xref rid="Tab8" ref-type="table">8</xref>).</p></sec></sec><sec id="Sec29"><title>ADMET analysis</title><p id="Par94">The pharmacokinetic properties of both the ester derivatives were further studied by in silico ADMET analysis<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. The optimal range of natural product (NP) score is -5 to 5, 4-carvomenthenol ester possessed greater natural product-likeness with NP score of 2.772 as compared to &#945;-terpineol ester with NP score 2.192 (Table&#160;<xref rid="Tab9" ref-type="table">9</xref>). Absorption parameters include Caco-2 permeability which indicates the absorption of drugs administered orally. The ideal value should be greater than &#8722;&#8201;5.15. Here, 4-carvomenthenol ester has greater Caco-2 permeability than &#945;-terpineol ester (Table&#160;<xref rid="Tab9" ref-type="table">9</xref>). P-glycoprotein (Pgp) is an efflux transporter that pumps drugs out of cells, potentially limiting their absorption and distribution. A low Pgp substrate value of 4-carvomenthenol ester (0.018) means the drug is less likely to be effluxed and has better potential for absorption and distribution throughout the body. Moreover, 4-carvomenthenol ester (0.009) showed slightly greater human intestinal absorption (HIA) than &#945;-terpineol ester (0.006). Greater HIA indicates that the drugs exhibit more effective intestinal absorption after being taken orally. The various sugar esters revealed a greater HIA value in comparison to the parent galactose<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>.</p><p id="Par95">
<table-wrap id="Tab9" position="float" orientation="portrait"><label>Table 9</label><caption><p>ADMET analysis of ester derivatives.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">S. No</th><th align="left" rowspan="2" colspan="1">Properties</th><th align="left" colspan="2" rowspan="1">Compounds</th></tr><tr><th align="left" colspan="1" rowspan="1">&#945;-terpineol ester</th><th align="left" colspan="1" rowspan="1">4-carvomenthenol ester</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Lipinski rule</td><td align="left" colspan="1" rowspan="1">Accepted</td><td align="left" colspan="1" rowspan="1">Accepted</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">NP score (-5 to 5)</td><td align="left" colspan="1" rowspan="1">2.192</td><td align="left" colspan="1" rowspan="1">2.772</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">Caco-2 permeability (&gt;&#8201;-5.15)</td><td align="left" colspan="1" rowspan="1">-4.525</td><td align="left" colspan="1" rowspan="1">-4.505</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Pgp-substrate (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.216</td><td align="left" colspan="1" rowspan="1">0.018</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Human Intestinal Absorption (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.006</td><td align="left" colspan="1" rowspan="1">0.009</td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">Blood&#8211;Brain Barrier (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.507</td><td align="left" colspan="1" rowspan="1">0.269</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">Fraction unbound in plasma</td><td align="left" colspan="1" rowspan="1">32.765</td><td align="left" colspan="1" rowspan="1">15.195</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">CYP2C9 inhibitor (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.316</td><td align="left" colspan="1" rowspan="1">0.393</td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">CYP2C9 substrate (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.118</td><td align="left" colspan="1" rowspan="1">0.405</td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">CYP2D6 inhibitor (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.184</td><td align="left" colspan="1" rowspan="1">0.143</td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">CYP2D6 substrate (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.063</td><td align="left" colspan="1" rowspan="1">0.155</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">CYP3A4 inhibitor (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.042</td><td align="left" colspan="1" rowspan="1">0.053</td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">CYP3A4 substrate (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.011</td><td align="left" colspan="1" rowspan="1">0.232</td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">CYP2B6 inhibitor (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.066</td><td align="left" colspan="1" rowspan="1">0.633</td></tr><tr><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">CYP2B6 substrate (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.084</td><td align="left" colspan="1" rowspan="1">0.929</td></tr><tr><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">Clearance (5&#8211;15)</td><td align="left" colspan="1" rowspan="1">8.282</td><td align="left" colspan="1" rowspan="1">8.662</td></tr><tr><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">Oral acute toxicity (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.230</td><td align="left" colspan="1" rowspan="1">0.156</td></tr><tr><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">Skin sensitization (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.926</td><td align="left" colspan="1" rowspan="1">0.803</td></tr><tr><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">Carcinogenicity (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.680</td><td align="left" colspan="1" rowspan="1">0.598</td></tr><tr><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">Eye corrosion (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.981</td><td align="left" colspan="1" rowspan="1">0.938</td></tr><tr><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">Eye irritation (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.992</td><td align="left" colspan="1" rowspan="1">0.967</td></tr><tr><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">Respiratory toxicity (0&#8211;1)</td><td align="left" colspan="1" rowspan="1">0.304</td><td align="left" colspan="1" rowspan="1">0.236</td></tr></tbody></table></table-wrap>
</p><p id="Par96">In order to understand the distribution of drug molecules, blood brain barrier penetration (must be low for non-CNS drugs) and fraction unbound in plasma (must be low for favourable pharmacokinetics) were the key factors. These parameters revealed the greater acceptance of 4-carvomenthenol ester with lower values of both parameters in comparison to &#945;-terpineol ester (Table&#160;<xref rid="Tab9" ref-type="table">9</xref>). To study drug metabolism in humans, cytochrome P450 enzymes (CYP enzymes) are essential. CYPs are a superfamily of heme-containing proteins that facilitate the oxidative reactions of various compounds, including fatty acids, steroids, and xenobiotics. They play a crucial role in drug metabolism, accounting for around 50% of all metabolic processes involving drugs. CYPs catalyse several reactions, including C and O oxidation, O-dealkylation, N-dealkylation, S-oxidation, N-oxidation, aromatic hydroxylation, deamination, and dehalogenation. In humans, there are roughly 100 isoforms of CYPs, primarily acting in the liver<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Additionally, drug toxicities&#8212;including sub-therapeutic or supra-therapeutic effects, drug interactions, antagonism, accumulation, liver complications, and hepatotoxicity&#8212;are closely linked to the interaction of drugs with key cytochrome P-450 (CYP) mixed-function oxidase isoenzymes, specifically CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Ideally, antibiotics should be substrates for these enzymes, allowing them to be efficiently metabolized. This ensures the drug is processed and eliminated predictably, supporting stable pharmacokinetics. Lipophilicity plays a crucial role in the binding of a substrate to cytochrome P450. As lipophilicity increases, the metabolic clearance of a drug also tends to rise<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. Antibiotics that do not significantly inhibit CYP enzymes are preferred, as they are less likely to disrupt the metabolism of other medications, thereby reducing the potential for harmful drug interactions<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Among both the esters, 4-carvomenthenol ester exhibited the greater substrate probability, thus predicting good rate of metabolism in comparison to &#945;-terpineol ester (Table&#160;<xref rid="Tab9" ref-type="table">9</xref>).</p><p id="Par97">In excretion, the clearance (CL) parameter was studied whose normal limit ranges from 5 to 15 indicating moderate elimination of drug molecules from the body. The CL values of both ester derivatives lie within the required range and are comparable. Among toxicity parameters, both the ester derivatives showed little probability of oral acute toxicity, carcinogenicity and respiratory toxicity. However, they may cause skin sensitization, eye irritation and eye corrosion to some extent with 4-carvomenthenol ester being less toxic than &#945;-terpineol ester (Table&#160;<xref rid="Tab9" ref-type="table">9</xref>).</p></sec></sec><sec id="Sec30"><title>Conclusion</title><p id="Par98">Hence, out of &#945;-terpineol, 4-carvomenthenol and their derivatives, &#945;-terpineol ester and 4-carvomenthenol ester exhibited the strongest antibacterial activity by causing damage to the bacterial cell membrane leading to leakage of cellular components. Both the ester derivatives revealed synergistic interaction with streptomycin and showed intermediate to weak biofilm formation in combination with streptomycin. Among the ester derivatives, &#945;-terpineol ester showed better binding with DNA gyrase and transpeptidase than 4-carvomenthenol ester. Both the ester derivatives also possessed favourable physicochemical properties and a strong pharmacokinetic profile, meeting all the criteria for drug likeliness. Therefore, both the ester derivatives can be considered promising antibacterial drug candidates. However, its effectiveness in animal infection models should be evaluated in future in vivo research.</p><sec id="Sec31"><title>Future perspective</title><p id="Par99">The promising findings from this study on &#945;-terpineol and 4-carvomenthenol esters highlight their potential as novel antimicrobial agents. Future research should focus on several key areas to fully explore and harness the therapeutic applications of these compounds. Conducting thorough safety and toxicity studies is essential to evaluate the viability of these compounds for therapeutic use. This includes in vivo studies to ensure safe application in clinical settings. The study of synergistic interactions between &#945;-terpineol/4-carvomenthenol, &#945;-terpineol ester /4-carvomenthenol ester and ester derivatives with other antibiotics may be carried forward so as to lower their MIC values. Along with this, future research may be directed towards the development of various nanoformulations of ester derivatives for their targeted and controlled release. Investigating the environmental effects of using these compounds, particularly in agricultural applications, will provide insights into their sustainability and potential for use in eco-friendly antimicrobial solutions. By addressing these areas, future research can significantly contribute to the development of &#945;-terpineol and 4-carvomenthenol esters as viable antimicrobial agents, potentially leading to innovative treatments in the fight against infectious diseases.</p></sec></sec><sec id="Sec33" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2025_3152_MOESM1_ESM.pptx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2025_3152_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 2</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>V.K.: Methodology, Investigation, Visualization, Software, Data curation, Writing- review and editing, Writing- Original manuscript. S.K.: Conceptualization, Supervision, Writing- review and editing, Validation, Project administration, Visualization, Resources. A.K.: Method validation, Resources, Visualization. R.J.: Visualization, Software, Writing- review and editing.P.S.: Validation, Visualization.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data will be made available on request from corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par101">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Lagha, O. M. B. Phytochemical profile, antimicrobial activity of nutmeg (<italic toggle="yes">Myristica fragrans</italic> Houtt.) seed extract and its efficacy as preservative for beef and shrimp. Ph.D. dissertation. School of graduate studies, University Putra Malaysia (2019).</mixed-citation></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullah</surname><given-names>F</given-names></name><etal/></person-group><article-title>Potential role of plant extracts and phytochemicals against foodborne pathogens</article-title><source>Appl. Sci.</source><year>2020</year><volume>10</volume><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.3390/app10134597</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ullah, F. et al. Potential role of plant extracts and phytochemicals against foodborne pathogens. <italic toggle="yes">Appl. Sci.</italic><bold>10</bold>, 256&#8211;262 (2020).</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamali</surname><given-names>SN</given-names></name><name name-style="western"><surname>Assadpour</surname><given-names>E</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J</given-names></name><name name-style="western"><surname>Jafari</surname><given-names>SM</given-names></name></person-group><article-title>Natural antimicrobial-loaded nanoemulsions for the control of food spoilage/pathogenic microorganisms</article-title><source>Adv. Colloid Interface Sci.</source><year>2021</year><volume>295</volume><fpage>56</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.cis.2021.102504</pub-id><pub-id pub-id-type="pmid">34384999</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Jamali, S. N., Assadpour, E., Feng, J. &amp; Jafari, S. M. Natural antimicrobial-loaded nanoemulsions for the control of food spoilage/pathogenic microorganisms. <italic toggle="yes">Adv. Colloid Interface Sci.</italic><bold>295</bold>, 56&#8211;72 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cis.2021.102504</pub-id><pub-id pub-id-type="pmid">34384999</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baym</surname><given-names>M</given-names></name><name name-style="western"><surname>Stone</surname><given-names>L</given-names></name><name name-style="western"><surname>Kishony</surname><given-names>R</given-names></name></person-group><article-title>Multidrug evolutionary strategies to reverse antibiotic resistance</article-title><source>Science</source><year>2015</year><volume>351</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aad3292</pub-id><pub-id pub-id-type="pmcid">PMC5496981</pub-id><pub-id pub-id-type="pmid">26722002</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Baym, M., Stone, L. &amp; Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. <italic toggle="yes">Science</italic><bold>351</bold>, 1&#8211;9 (2015).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aad3292</pub-id><pub-id pub-id-type="pmcid">PMC5496981</pub-id><pub-id pub-id-type="pmid">26722002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lather</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Khatkar</surname><given-names>A</given-names></name></person-group><article-title>Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>13903</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-70895-1</pub-id><pub-id pub-id-type="pmid">32807915</pub-id><pub-id pub-id-type="pmcid">PMC7431536</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Lather, A., Sharma, S. &amp; Khatkar, A. Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products. <italic toggle="yes">Sci. Rep.</italic><bold>10</bold>, 13903 (2020).<pub-id pub-id-type="pmid">32807915</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-70895-1</pub-id><pub-id pub-id-type="pmcid">PMC7431536</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Pisoschi, A. M. et al. An overview of natural antimicrobials role in food. <italic toggle="yes">Eur. J. Med. Chem.</italic> 17, (2017). 10.1016/j.ejmech.2017.11.095<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2017.11.095</pub-id><pub-id pub-id-type="pmid">29227932</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Hayek, S. A., Gyawali, R. &amp; Ibrahim, S. A. Antimicrobial natural products in Microbial pathogens and strategies for combating them: science, technology and education (ed. Mendez-Vilas, A) 910&#8211;921Greensboro, USA (2013).</mixed-citation></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fratianni</surname><given-names>F</given-names></name><etal/></person-group><article-title>Preservation of chicken breast meat treated with thyme and balm essential oils</article-title><source>J. Food Sci.</source><year>2010</year><volume>75</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2010.01791.x</pub-id><pub-id pub-id-type="pmid">21535509</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Fratianni, F. et al. Preservation of chicken breast meat treated with thyme and balm essential oils. <italic toggle="yes">J. Food Sci.</italic><bold>75</bold>, 1&#8211;8 (2010).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1750-3841.2010.01791.x</pub-id><pub-id pub-id-type="pmid">21535509</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarkar</surname><given-names>T</given-names></name><etal/></person-group><article-title>Minor tropical fruits as a potential source of bioactive and functional foods</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2023</year><volume>63</volume><fpage>6491</fpage><lpage>6535</lpage><pub-id pub-id-type="doi">10.1080/10408398.2022.2033953</pub-id><pub-id pub-id-type="pmid">35164626</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Sarkar, T. et al. Minor tropical fruits as a potential source of bioactive and functional foods. <italic toggle="yes">Crit. Rev. Food Sci. Nutr.</italic><bold>63</bold>, 6491&#8211;6535 (2023).<pub-id pub-id-type="pmid">35164626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408398.2022.2033953</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Kaur, V., Kaushal, S., Kalia, A. &amp; Heena Nutmeg vs mace: Evaluation of functional, nutritional, antioxidant and antimicrobial traits to employ as a food preservative. <italic toggle="yes">Food Biosci</italic>. <bold>62</bold>10.1016/j.fbio.2024.105193 (2024).</mixed-citation></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahizan</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Terpene derivatives as a potential agent against antimicrobial resistance (AMR) pathogens</article-title><source>Molecules</source><year>2019</year><volume>24</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3390/molecules24142631</pub-id><pub-id pub-id-type="pmcid">PMC6680751</pub-id><pub-id pub-id-type="pmid">31330955</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Mahizan, N. A. et al. Terpene derivatives as a potential agent against antimicrobial resistance (AMR) pathogens. <italic toggle="yes">Molecules</italic><bold>24</bold>, 1&#8211;21 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules24142631</pub-id><pub-id pub-id-type="pmcid">PMC6680751</pub-id><pub-id pub-id-type="pmid">31330955</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>MB</given-names></name><name name-style="western"><surname>Martin</surname><given-names>GP</given-names></name><name name-style="western"><surname>Jones</surname><given-names>SA</given-names></name><name name-style="western"><surname>Akomeah</surname><given-names>FK</given-names></name></person-group><article-title>Dermal and transdermal drug delivery systems: current and future prospects</article-title><source>Drug Deliv</source><year>2006</year><volume>13</volume><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1080/10717540500455975</pub-id><pub-id pub-id-type="pmid">16556569</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Brown, M. B., Martin, G. P., Jones, S. A. &amp; Akomeah, F. K. Dermal and transdermal drug delivery systems: Current and future prospects. <italic toggle="yes">Drug Deliv</italic>. <bold>13</bold>, 175&#8211;187 (2006).<pub-id pub-id-type="pmid">16556569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10717540500455975</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khaleel</surname><given-names>C</given-names></name><name name-style="western"><surname>Tabanca</surname><given-names>N</given-names></name><name name-style="western"><surname>Buchbauer</surname><given-names>G</given-names></name></person-group><article-title>&#945;-terpineol, a natural monoterpene: A review of its biological properties</article-title><source>Open. Chem.</source><year>2018</year><volume>16</volume><fpage>349</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1515/chem-2018-0040</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Khaleel, C., Tabanca, N. &amp; Buchbauer, G. &#945;-terpineol, a natural monoterpene: A review of its biological properties. <italic toggle="yes">Open. Chem.</italic><bold>16</bold>, 349&#8211;361 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhatia</surname><given-names>SP</given-names></name><name name-style="western"><surname>Letizia</surname><given-names>CS</given-names></name><name name-style="western"><surname>Api</surname><given-names>AM</given-names></name></person-group><article-title>Fragrance material review on alpha-terpineol</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2008.06.027</pub-id><pub-id pub-id-type="pmid">18640180</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Bhatia, S. P., Letizia, C. S. &amp; Api, A. M. Fragrance material review on alpha-terpineol. <italic toggle="yes">Food Chem. Toxicol.</italic><bold>46</bold>, 280&#8211;285 (2008).<pub-id pub-id-type="pmid">18644418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fct.2008.06.081</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Held</surname><given-names>S</given-names></name><name name-style="western"><surname>Schieberle</surname><given-names>P</given-names></name><name name-style="western"><surname>Somoza</surname><given-names>V</given-names></name></person-group><article-title>Characterization of alpha-terpineol as an anti-inflammatory component of orange juice by <italic toggle="yes">in vitro</italic> studies using oral buccal cells</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>8040</fpage><lpage>8046</lpage><pub-id pub-id-type="doi">10.1021/jf071691m</pub-id><pub-id pub-id-type="pmid">17867636</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Held, S., Schieberle, P. &amp; Somoza, V. Characterization of alpha-terpineol as an anti-inflammatory component of orange juice by <italic toggle="yes">in vitro</italic> studies using oral buccal cells. <italic toggle="yes">J. Agric. Food Chem.</italic><bold>55</bold>, 8040&#8211;8046 (2007).<pub-id pub-id-type="pmid">17867636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jf071691m</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lampronti</surname><given-names>I</given-names></name><name name-style="western"><surname>Saab</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gambari</surname><given-names>A</given-names></name></person-group><article-title>Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division</article-title><source>Int. J. Oncol.</source><year>2006</year><volume>29</volume><fpage>989</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">16964395</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Lampronti, I., Saab, A. M. &amp; Gambari, A. Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. <italic toggle="yes">Int. J. Oncol.</italic><bold>29</bold>, 989&#8211;995 (2006).<pub-id pub-id-type="pmid">16964395</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sabino</surname><given-names>CK</given-names></name><name name-style="western"><surname>Ferreria-Filho</surname><given-names>ES</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>MB</given-names></name></person-group><article-title>Da Silva-Filho, J. C. Cardiovascular effects induced by &#945;-terpineol in hypertensive rats</article-title><source>Flavour. Frag J.</source><year>2013</year><volume>28</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1002/ffj.3159</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Sabino, C. K., Ferreria-Filho, E. S. &amp; Mendes, M. B. Da Silva-Filho, J. C. Cardiovascular effects induced by &#945;-terpineol in hypertensive rats. <italic toggle="yes">Flavour. Frag J.</italic><bold>28</bold>, 333&#8211;339 (2013).</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davit</surname><given-names>H</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>S</given-names></name><name name-style="western"><surname>Hunjan</surname><given-names>MS</given-names></name></person-group><article-title>Chemical composition and antibacterial potential of <italic toggle="yes">Terminalia Arjuna</italic> (Roxb. Ex DC.) Wight Arn. Leaves essential oil against phytopathogenic bacteria of rice and potato</article-title><source>J. Essent. Oil-Bear Plants</source><year>2022</year><volume>25</volume><fpage>468</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2022.2105661</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Davit, H., Kaushal, S. &amp; Hunjan, M. S. Chemical composition and antibacterial potential of <italic toggle="yes">Terminalia Arjuna</italic> (Roxb. Ex DC.) Wight Arn. Leaves essential oil against phytopathogenic bacteria of rice and potato. <italic toggle="yes">J. Essent. Oil-Bear Plants</italic>. <bold>25</bold>, 468&#8211;481 (2022).</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>B</given-names></name><name name-style="western"><surname>Duval</surname><given-names>RE</given-names></name><name name-style="western"><surname>Sergere</surname><given-names>JC</given-names></name></person-group><article-title>First evidence of a combination of terpinen-4-ol and &#945;-terpineol as a promising tool against ESKAPE pathogens</article-title><source>Molecules</source><year>2022</year><volume>27</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.3390/molecules27217472</pub-id><pub-id pub-id-type="pmcid">PMC9654757</pub-id><pub-id pub-id-type="pmid">36364298</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Johansen, B., Duval, R. E. &amp; Sergere, J. C. First evidence of a combination of terpinen-4-ol and &#945;-terpineol as a promising tool against ESKAPE pathogens. <italic toggle="yes">Molecules</italic><bold>27</bold>, 1&#8211;18 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules27217472</pub-id><pub-id pub-id-type="pmcid">PMC9654757</pub-id><pub-id pub-id-type="pmid">36364298</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konuk</surname><given-names>BH</given-names></name><name name-style="western"><surname>Erguden</surname><given-names>B</given-names></name></person-group><article-title>Phenolic &#8211;OH group is crucial for the antifungal activity of terpenoids via disruption of cell membrane integrity</article-title><source>Folia Microbiol.</source><year>2020</year><volume>65</volume><fpage>775</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1007/s12223-020-00787-4</pub-id><pub-id pub-id-type="pmid">32193708</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Konuk, B. H. &amp; Erguden, B. Phenolic &#8211;OH group is crucial for the antifungal activity of terpenoids via disruption of cell membrane integrity. <italic toggle="yes">Folia Microbiol.</italic><bold>65</bold>, 775&#8211;783 (2020).<pub-id pub-id-type="pmid">32193708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12223-020-00787-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The antibacterial mechanism of terpinen-4-ol against <italic toggle="yes">Streptococcus agalactiae</italic></article-title><source>Curr. Microbiol.</source><year>2018</year><volume>75</volume><fpage>1214</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1007/s00284-018-1512-2</pub-id><pub-id pub-id-type="pmid">29804206</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zhang, Y. et al. The antibacterial mechanism of terpinen-4-ol against <italic toggle="yes">Streptococcus agalactiae</italic>. <italic toggle="yes">Curr. Microbiol.</italic><bold>75</bold>, 1214&#8211;1220 (2018).<pub-id pub-id-type="pmid">29804206</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00284-018-1512-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name></person-group><article-title>Discovery of a novel series of &#945;-terpineol derivatives as promising anti-asthmatic agents: their design, synthesis, and biological evaluation</article-title><source>Eur. J. Med. Chem.</source><year>2018</year><volume>143</volume><fpage>419</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2017.07.068</pub-id><pub-id pub-id-type="pmid">29202404</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Zhu, W., Liu, X., Wang, Y., Tong, Y. &amp; Hu, Y. Discovery of a novel series of &#945;-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation. <italic toggle="yes">Eur. J. Med. Chem.</italic><bold>143</bold>, 419&#8211;425 (2018).<pub-id pub-id-type="pmid">29202404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2017.07.068</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Adam, R. P. <italic toggle="yes">Identification of Essential Oil Components by Gas Chromatography/mass Spectrometry</italic> 4th edn (Allured Publishing Corporation, 2007).</mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">de Carvalho, B. L. C., Aguillon, A. R., Leao, R. A. C. &amp; de Souza, R. O. M. A. Two-step continuous-flow synthesis of &#945;-terpineol. <italic toggle="yes">Beilstein Arch.</italic> 1&#8211;15 (2020). (2020).</mixed-citation></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>K</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>S</given-names></name><name name-style="western"><surname>Rani</surname><given-names>R</given-names></name></person-group><article-title>Chemical composition, antioxidant and antifungal potential of clove (<italic toggle="yes">Syzygium aromaticum</italic>) essential oil, its major compound and its derivatives</article-title><source>J. Essent. Oil-Bear Plants</source><year>2019</year><volume>22</volume><fpage>1195</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2019.1688689</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Kaur, K., Kaushal, S. &amp; Rani, R. Chemical composition, antioxidant and antifungal potential of clove (<italic toggle="yes">Syzygium aromaticum</italic>) essential oil, its major compound and its derivatives. <italic toggle="yes">J. Essent. Oil-Bear Plants</italic>. <bold>22</bold>, 1195&#8211;1217 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jassal</surname><given-names>K</given-names></name><name name-style="western"><surname>Kaushal</surname><given-names>S</given-names></name><name name-style="western"><surname>Rani</surname><given-names>R</given-names></name></person-group><article-title>Antifungal potential of guava (<italic toggle="yes">Psidium guajava</italic>) leaves essential oil, major compounds: beta-caryophyllene and caryophyllene oxide</article-title><source>Arch. Phytopathol. Plant. Prot.</source><year>2021</year><volume>54</volume><fpage>2034</fpage><lpage>2050</lpage><pub-id pub-id-type="doi">10.1080/03235408.2021.1968287</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Jassal, K., Kaushal, S., Rani, R. &amp; Rashmi. &amp; Antifungal potential of guava (<italic toggle="yes">Psidium guajava</italic>) leaves essential oil, major compounds: beta-caryophyllene and caryophyllene oxide. <italic toggle="yes">Arch. Phytopathol. Plant. Prot.</italic><bold>54</bold>, 2034&#8211;2050 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>RG</given-names></name><name name-style="western"><surname>Vanterpool</surname><given-names>R</given-names></name><name name-style="western"><surname>Kula</surname><given-names>HJ</given-names></name></person-group><article-title>Dimethyl sulfoxide as a solvent in the williamson ether synthesis</article-title><source>Can. J. Chem.</source><year>1968</year><volume>47</volume><fpage>2015</fpage><lpage>2019</lpage><pub-id pub-id-type="doi">10.1139/v69-325</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Smith, R. G., Vanterpool, R. &amp; Kula, H. J. Dimethyl sulfoxide as a solvent in the williamson ether synthesis. <italic toggle="yes">Can. J. Chem.</italic><bold>47</bold>, 2015&#8211;2019 (1968).</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Thapa, R. Regioselectivity in free radical bromination of unsymmetrical dimethylated pyridines. Msc thesis. Miami University, Oxford, Ohio (2009).</mixed-citation></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><collab>Heena</collab></person-group><article-title>Isolation of Quinic acid from dropped <italic toggle="yes">Citrus reticulata</italic> Blanco fruits: its derivatization, antibacterial potential, Docking studies, and ADMET profiling</article-title><source>Front. Chem.</source><year>2024</year><volume>12</volume><fpage>1372560</fpage><pub-id pub-id-type="doi">10.3389/fchem.2024.1372560</pub-id><pub-id pub-id-type="pmid">38698937</pub-id><pub-id pub-id-type="pmcid">PMC11064019</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Heena. Isolation of Quinic acid from dropped <italic toggle="yes">Citrus reticulata</italic> Blanco fruits: Its derivatization, antibacterial potential, Docking studies, and ADMET profiling. <italic toggle="yes">Front. Chem.</italic><bold>12</bold>, 1372560 (2024).<pub-id pub-id-type="pmid">38698937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fchem.2024.1372560</pub-id><pub-id pub-id-type="pmcid">PMC11064019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pourkhosravani</surname><given-names>E</given-names></name><name name-style="western"><surname>Nayeri</surname><given-names>FD</given-names></name><name name-style="western"><surname>Bazargani</surname><given-names>MM</given-names></name></person-group><article-title>Decoding antibacterial and antibiofilm properties of cinnamon and cardamom essential oils: A combined molecular Docking and experimental study</article-title><source>AMB Expr</source><year>2021</year><volume>11</volume><fpage>143</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1186/s13568-021-01305-6</pub-id><pub-id pub-id-type="pmcid">PMC8548479</pub-id><pub-id pub-id-type="pmid">34704145</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Pourkhosravani, E., Nayeri, F. D. &amp; Bazargani, M. M. Decoding antibacterial and antibiofilm properties of cinnamon and cardamom essential oils: A combined molecular Docking and experimental study. <italic toggle="yes">AMB Expr</italic>. <bold>11</bold>, 143&#8211;161 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13568-021-01305-6</pub-id><pub-id pub-id-type="pmcid">PMC8548479</pub-id><pub-id pub-id-type="pmid">34704145</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutierrez</surname><given-names>J</given-names></name><name name-style="western"><surname>Barry-Ryan</surname><given-names>C</given-names></name><name name-style="western"><surname>Bourke</surname><given-names>P</given-names></name></person-group><article-title>Antimicrobial activity of plant essential oils using food model media: efficacy, synergistic potential and interactions with food components</article-title><source>Food Microbiol.</source><year>2009</year><volume>26</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2008.10.008</pub-id><pub-id pub-id-type="pmid">19171255</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Gutierrez, J., Barry-Ryan, C. &amp; Bourke, P. Antimicrobial activity of plant essential oils using food model media: Efficacy, synergistic potential and interactions with food components. <italic toggle="yes">Food Microbiol.</italic><bold>26</bold>, 142&#8211;150 (2009).<pub-id pub-id-type="pmid">19171255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fm.2008.10.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez</surname><given-names>E</given-names></name><etal/></person-group><article-title>Antibacterial and antibiofilm activity of methanolic plant extracts against nosocomial microorganisms</article-title><source>Evid. Based Complement. Alternat Med.</source><year>2016</year><volume>10</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2016/1572697</pub-id><pub-id pub-id-type="pmcid">PMC4939345</pub-id><pub-id pub-id-type="pmid">27429633</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Sanchez, E. et al. Antibacterial and antibiofilm activity of methanolic plant extracts against nosocomial microorganisms. <italic toggle="yes">Evid. Based Complement. Alternat Med.</italic><bold>10</bold>, 1&#8211;8 (2016).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2016/1572697</pub-id><pub-id pub-id-type="pmcid">PMC4939345</pub-id><pub-id pub-id-type="pmid">27429633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>C</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>ES</given-names></name></person-group><article-title>Colorimetric method for identifying plant essential oil components that affect biofilm formation and structure</article-title><source>Appl. Environ. Microbiol.</source><year>2004</year><volume>70</volume><fpage>6951</fpage><lpage>6956</lpage><pub-id pub-id-type="doi">10.1128/AEM.70.12.6951-6956.2004</pub-id><pub-id pub-id-type="pmid">15574886</pub-id><pub-id pub-id-type="pmcid">PMC535164</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Niu, C. &amp; Gilbert, E. S. Colorimetric method for identifying plant essential oil components that affect biofilm formation and structure. <italic toggle="yes">Appl. Environ. Microbiol.</italic><bold>70</bold>, 6951&#8211;6956 (2004).<pub-id pub-id-type="pmid">15574886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AEM.70.12.6951-6956.2004</pub-id><pub-id pub-id-type="pmcid">PMC535164</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lafitte</surname><given-names>D</given-names></name><etal/></person-group><article-title>DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5&#8216;-methyl group of the noviose</article-title><source>Biochem</source><year>2002</year><volume>41</volume><fpage>7217</fpage><lpage>7223</lpage><pub-id pub-id-type="doi">10.1021/bi0159837</pub-id><pub-id pub-id-type="pmid">12044152</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Lafitte, D. et al. DNA gyrase interaction with coumarin-based inhibitors: The role of the hydroxybenzoate isopentenyl moiety and the 5&#8216;-methyl group of the noviose. <italic toggle="yes">Biochem</italic><bold>41</bold>, 7217&#8211;7223 (2002).<pub-id pub-id-type="pmid">12044152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi0159837</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>D</given-names></name><name name-style="western"><surname>Strynadka</surname><given-names>NC</given-names></name></person-group><article-title>J. Structural basis for the &#914; lactam resistance of PBP2a from methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Nat. Str. Biol.</source><year>2002</year><volume>9</volume><fpage>870</fpage><lpage>876</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nsb858</pub-id><pub-id pub-id-type="pmid">12389036</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Lim, D. &amp; Strynadka, N. C. J. Structural basis for the &#914; lactam resistance of PBP2a from methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>. <italic toggle="yes">Nat. Str. Biol.</italic><bold>9</bold>, 870&#8211;876 (2002).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nsb858</pub-id><pub-id pub-id-type="pmid">12389036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>GM</given-names></name><etal/></person-group><article-title>AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility</article-title><source>J. Comput. Chem.</source><year>2009</year><volume>30</volume><fpage>2785</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id><pub-id pub-id-type="pmid">19399780</pub-id><pub-id pub-id-type="pmcid">PMC2760638</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated Docking with selective receptor flexibility. <italic toggle="yes">J. Comput. Chem.</italic><bold>30</bold>, 2785&#8211;2791 (2009).<pub-id pub-id-type="pmid">19399780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcc.21256</pub-id><pub-id pub-id-type="pmcid">PMC2760638</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gasteiger</surname><given-names>J</given-names></name><name name-style="western"><surname>Marsili</surname><given-names>M</given-names></name></person-group><article-title>Iterative partial equalization of orbital electronegativity&#8212;a rapid access to atomic charges</article-title><source>Tetrahedron</source><year>1980</year><volume>36</volume><fpage>3219</fpage><lpage>3228</lpage><pub-id pub-id-type="doi">10.1016/0040-4020(80)80168-2</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gasteiger, J. &amp; Marsili, M. Iterative partial equalization of orbital electronegativity&#8212;a rapid access to atomic charges. <italic toggle="yes">Tetrahedron</italic><bold>36</bold>, 3219&#8211;3228 (1980).</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos-Martins</surname><given-names>D</given-names></name><etal/></person-group><article-title>Accelerating AutoDock4 with GPUs and gradient-based local search</article-title><source>J. Chem. Theory Comput.</source><year>2021</year><volume>17</volume><fpage>1060</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.0c01006</pub-id><pub-id pub-id-type="pmid">33403848</pub-id><pub-id pub-id-type="pmcid">PMC8063785</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Santos-Martins, D. et al. Accelerating AutoDock4 with GPUs and gradient-based local search. <italic toggle="yes">J. Chem. Theory Comput.</italic><bold>17</bold>, 1060&#8211;1073 (2021).<pub-id pub-id-type="pmid">33403848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jctc.0c01006</pub-id><pub-id pub-id-type="pmcid">PMC8063785</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solis</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Wets</surname><given-names>RJ</given-names></name></person-group><article-title>B. Minimization by random search techniques</article-title><source>Math. Oper. Res.</source><year>1981</year><volume>6</volume><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1287/moor.6.1.19</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Solis, F. J. &amp; Wets, R. J. B. Minimization by random search techniques. <italic toggle="yes">Math. Oper. Res.</italic><bold>6</bold>, 19&#8211;30 (1981).</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>GM</given-names></name></person-group><article-title>Automated Docking using a Lamarckian genetic algorithm and an empirical binding free energy function</article-title><source>J. Comput. Chem.</source><year>1998</year><volume>19</volume><fpage>1639</fpage><lpage>1662</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1096-987X(19981115)19:14&amp;#x0003c;1639::AID-JCC10&amp;#x0003e;3.0.CO;2-B</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Morris, G. M. Automated Docking using a Lamarckian genetic algorithm and an empirical binding free energy function. <italic toggle="yes">J. Comput. Chem.</italic><bold>19</bold>, 1639&#8211;1662 (1998).</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Schrodinger, L. L. C. The PyMOL Molecular Graphics System, Version 1.8. (2015).</mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">BIOVIA, Discovery Studio Client, v24.1.0.23298. San Diego: Dassault Syst&#232;mes (2023).</mixed-citation></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kishor</surname><given-names>KHG</given-names></name><etal/></person-group><article-title>Biological activity prediction and Docking studies of main phytoconstituents present in eucalyptus using computational tools</article-title><source>Int. J. Innov. Sci. Res. Technol.</source><year>2023</year><volume>8</volume><fpage>1332</fpage><lpage>1343</lpage></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kishor, K. H. G. et al. Biological activity prediction and Docking studies of main phytoconstituents present in eucalyptus using computational tools. <italic toggle="yes">Int. J. Innov. Sci. Res. Technol.</italic><bold>8</bold>, 1332&#8211;1343 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyle</surname><given-names>NMO</given-names></name><etal/></person-group><article-title>Open babel: an open chemical toolbox</article-title><source>J. Cheminf</source><year>2011</year><volume>3</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id><pub-id pub-id-type="pmcid">PMC3198950</pub-id><pub-id pub-id-type="pmid">21982300</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Boyle, N. M. O. et al. Open babel: An open chemical toolbox. <italic toggle="yes">J. Cheminf</italic>. <bold>3</bold>, 1&#8211;14 (2011).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1758-2946-3-33</pub-id><pub-id pub-id-type="pmcid">PMC3198950</pub-id><pub-id pub-id-type="pmid">21982300</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">SAS Institute &amp; Inc <italic toggle="yes">SAS User&#8217;s Guide: Statistics, Version 5 Ed</italic> 11141&#8211;50 (SAS Institute, Inc, 1989).</mixed-citation></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantrell</surname><given-names>CL</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A</given-names></name><name name-style="western"><surname>Jones</surname><given-names>AMP</given-names></name></person-group><article-title>Isolation and identification of mosquito biting deterrents from the North American mosquito repelling folk remedy plant, <italic toggle="yes">Matricaria discoidea</italic> DC</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0206594</pub-id><pub-id pub-id-type="pmcid">PMC6209309</pub-id><pub-id pub-id-type="pmid">30379955</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Cantrell, C. L., Ali, A. &amp; Jones, A. M. P. Isolation and identification of mosquito biting deterrents from the North American mosquito repelling folk remedy plant, <italic toggle="yes">Matricaria discoidea</italic> DC. <italic toggle="yes">PLoS ONE</italic>. <bold>13</bold>, 1&#8211;12 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0206594</pub-id><pub-id pub-id-type="pmcid">PMC6209309</pub-id><pub-id pub-id-type="pmid">30379955</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Cunningham, W. Catalytic conversion of terpene feedstocks into value-added chemicals and commodity chemicals. Ph.D. dissertation. University of Bath, England (2018).</mixed-citation></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>H</given-names></name></person-group><article-title>Williamson ether synthesis: o-alkylation reaction using halogenated hydrocarbons as alkylating agents</article-title><source>Acad. J. Mater. Chem.</source><year>2023</year><volume>4</volume><fpage>41</fpage><lpage>45</lpage></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Duan, H. Williamson ether synthesis: o-alkylation reaction using halogenated hydrocarbons as alkylating agents. <italic toggle="yes">Acad. J. Mater. Chem.</italic><bold>4</bold>, 41&#8211;45 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">You, C. et al. Identification of repellent and insecticidal constituents from Artemisia mongolica essential oil against <italic toggle="yes">Lasioderma serricorne</italic>. <italic toggle="yes">J. Chem.</italic> 1&#8211;7 (2015). (2015).</mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Silva, R. H. N. et al. Antimicrobial activity of 4-chlorocinnamic acid derivatives. <italic toggle="yes">Biomed. Res. Int.</italic> 1&#8211;13 (2019). (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/3941242</pub-id><pub-id pub-id-type="pmcid">PMC6507161</pub-id><pub-id pub-id-type="pmid">31179320</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kopecna</surname><given-names>M</given-names></name><etal/></person-group><article-title>Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-019-51226-5</pub-id><pub-id pub-id-type="pmid">31601936</pub-id><pub-id pub-id-type="pmcid">PMC6787078</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Kopecna, M. et al. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 1&#8211;12 (2019).<pub-id pub-id-type="pmid">31601936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-51226-5</pub-id><pub-id pub-id-type="pmcid">PMC6787078</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blajet</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Kubis</surname><given-names>JF</given-names></name></person-group><article-title>Monoterpenes and their derivatives-recent development in biological and medical applications</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><fpage>1</fpage><lpage>38</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21197078</pub-id><pub-id pub-id-type="pmcid">PMC7582973</pub-id><pub-id pub-id-type="pmid">32992914</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Blajet, M. Z. &amp; Kubis, J. F. Monoterpenes and their derivatives-recent development in biological and medical applications. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 1&#8211;38 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21197078</pub-id><pub-id pub-id-type="pmcid">PMC7582973</pub-id><pub-id pub-id-type="pmid">32992914</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathela</surname><given-names>CS</given-names></name><name name-style="western"><surname>Singh</surname><given-names>KK</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>VK</given-names></name></person-group><article-title>Synthesis and <italic toggle="yes">in vitro</italic> antibacterial activity of thymol and carvacrol derivatives</article-title><source>Acta Pol. Pharm.</source><year>2010</year><volume>67</volume><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">20635533</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Mathela, C. S., Singh, K. K. &amp; Gupta, V. K. Synthesis and <italic toggle="yes">in vitro</italic> antibacterial activity of thymol and carvacrol derivatives. <italic toggle="yes">Acta Pol. Pharm.</italic><bold>67</bold>, 375&#8211;380 (2010).<pub-id pub-id-type="pmid">20635533</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Silva</surname><given-names>FFM</given-names></name><etal/></person-group><article-title>Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities</article-title><source>Chem. Cent. J.</source><year>2018</year><volume>12</volume><fpage>34</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1186/s13065-018-0407-4</pub-id><pub-id pub-id-type="pmid">29611004</pub-id><pub-id pub-id-type="pmcid">PMC5880794</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">da Silva, F. F. M. et al. Eugenol derivatives: Synthesis, characterization, and evaluation of antibacterial and antioxidant activities. <italic toggle="yes">Chem. Cent. J.</italic><bold>12</bold>, 34&#8211;52 (2018).<pub-id pub-id-type="pmid">29611004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13065-018-0407-4</pub-id><pub-id pub-id-type="pmcid">PMC5880794</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gannett</surname><given-names>C</given-names></name><etal/></person-group><article-title>Semisynthetic Blasticidin S ester derivatives show enhanced antibiotic activity</article-title><source>RSC Med. Chem.</source><year>2023</year><volume>14</volume><fpage>782</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1039/D2MD00412G</pub-id><pub-id pub-id-type="pmid">37122539</pub-id><pub-id pub-id-type="pmcid">PMC10131614</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Gannett, C. et al. Semisynthetic Blasticidin S ester derivatives show enhanced antibiotic activity. <italic toggle="yes">RSC Med. Chem.</italic><bold>14</bold>, 782&#8211;789 (2023).<pub-id pub-id-type="pmid">37122539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d2md00412g</pub-id><pub-id pub-id-type="pmcid">PMC10131614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antoszczak</surname><given-names>M</given-names></name><etal/></person-group><article-title>Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic &#8211; salinomycin</article-title><source>Eur. J. Med. Chem.</source><year>2014</year><volume>76</volume><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2014.02.031</pub-id><pub-id pub-id-type="pmid">24602789</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Antoszczak, M. et al. Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic&#8212;salinomycin. <italic toggle="yes">Eur. J. Med. Chem.</italic><bold>76</bold>, 435&#8211;444 (2014).<pub-id pub-id-type="pmid">24602789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2014.02.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lather</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Khatkar</surname><given-names>A</given-names></name></person-group><article-title>Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: synthesis, antioxidants, antimicrobial, preservative efficacy, molecular Docking and in Silico ADMET analysis</article-title><source>BMC Chem.</source><year>2020</year><volume>14</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s13065-020-00693-3</pub-id><pub-id pub-id-type="pmid">32577624</pub-id><pub-id pub-id-type="pmcid">PMC7305605</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Lather, A., Sharma, S. &amp; Khatkar, A. Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: Synthesis, antioxidants, antimicrobial, preservative efficacy, molecular Docking and in Silico ADMET analysis. <italic toggle="yes">BMC Chem.</italic><bold>14</bold>, 41 (2020).<pub-id pub-id-type="pmid">32577624</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13065-020-00693-3</pub-id><pub-id pub-id-type="pmcid">PMC7305605</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>W</given-names></name><name name-style="western"><surname>Xin</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C</given-names></name><name name-style="western"><surname>Xia</surname><given-names>C</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name></person-group><article-title>Alkyl ferulic acid esters: evaluating their structure and antibacterial properties</article-title><source>Front. Microbiol.</source><year>2023</year><volume>14</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2023.1135308</pub-id><pub-id pub-id-type="pmcid">PMC9968881</pub-id><pub-id pub-id-type="pmid">36860482</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Song, W., Xin, J., Yu, C., Xia, C. &amp; Pan, Y. Alkyl ferulic acid esters: Evaluating their structure and antibacterial properties. <italic toggle="yes">Front. Microbiol.</italic><bold>14</bold>, 1&#8211;10 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2023.1135308</pub-id><pub-id pub-id-type="pmcid">PMC9968881</pub-id><pub-id pub-id-type="pmid">36860482</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>YG</given-names></name><etal/></person-group><article-title>Alkyl ferulate esters as multifunctional food additives: antibacterial activity and mode of action against <italic toggle="yes">Escherichia coli in vitro</italic></article-title><source>J. Agric. Food Chem.</source><year>2018</year><volume>66</volume><fpage>12088</fpage><lpage>12101</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.8b04429</pub-id><pub-id pub-id-type="pmid">30360622</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Shi, Y. G. et al. Alkyl ferulate esters as multifunctional food additives: Antibacterial activity and mode of action against <italic toggle="yes">Escherichia coli in vitro</italic>. <italic toggle="yes">J. Agric. Food Chem.</italic><bold>66</bold>, 12088&#8211;12101 (2018).<pub-id pub-id-type="pmid">30360622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jafc.8b04429</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Antibacterial activity and mechanism of three isomeric Terpineols of <italic toggle="yes">Cinnamomum longepaniculatum</italic> leaf oil</article-title><source>Folia Microbiol.</source><year>2021</year><volume>66</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s12223-020-00818-0</pub-id><pub-id pub-id-type="pmid">32895862</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Huang, J. et al. Antibacterial activity and mechanism of three isomeric Terpineols of <italic toggle="yes">Cinnamomum longepaniculatum</italic> leaf oil. <italic toggle="yes">Folia Microbiol.</italic><bold>66</bold>, 59&#8211;67 (2021).<pub-id pub-id-type="pmid">32895862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12223-020-00818-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antibacterial activity of &#945;-terpineol May induce morphostructural alterations in <italic toggle="yes">Escherichia coli</italic></article-title><source>Braz J. Microbiol.</source><year>2014</year><volume>45</volume><fpage>1409</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822014000400035</pub-id><pub-id pub-id-type="pmid">25763048</pub-id><pub-id pub-id-type="pmcid">PMC4323317</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Li, L. et al. Antibacterial activity of &#945;-terpineol May induce morphostructural alterations in <italic toggle="yes">Escherichia coli</italic>. <italic toggle="yes">Braz J. Microbiol.</italic><bold>45</bold>, 1409&#8211;1413 (2014).<pub-id pub-id-type="pmid">25763048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s1517-83822014000400035</pub-id><pub-id pub-id-type="pmcid">PMC4323317</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cordeiro</surname><given-names>L</given-names></name><etal/></person-group><article-title>Terpinen-4-ol as an antibacterial and antibiofilm agent against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3390/ijms21124531</pub-id><pub-id pub-id-type="pmcid">PMC7350221</pub-id><pub-id pub-id-type="pmid">32630600</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Cordeiro, L. et al. Terpinen-4-ol as an antibacterial and antibiofilm agent against <italic toggle="yes">Staphylococcus aureus</italic>. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 1&#8211;14 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21124531</pub-id><pub-id pub-id-type="pmcid">PMC7350221</pub-id><pub-id pub-id-type="pmid">32630600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>A</given-names></name><name name-style="western"><surname>Parihar</surname><given-names>DK</given-names></name></person-group><article-title>Antibacterial, biofilm dispersal and antibiofilm potential of alkaloids and flavonoids of Curcuma</article-title><source>Biocatal. Agric. Biotechnol.</source><year>2018</year><volume>16</volume><fpage>677</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1016/j.bcab.2018.09.023</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Jain, A. &amp; Parihar, D. K. Antibacterial, biofilm dispersal and antibiofilm potential of alkaloids and flavonoids of Curcuma. <italic toggle="yes">Biocatal. Agric. Biotechnol.</italic><bold>16</bold>, 677&#8211;682 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bordini</surname><given-names>EAF</given-names></name><etal/></person-group><article-title>Antimicrobial effects of terpinen-4-ol against oral pathogens and its capacity for the modulation of gene expression</article-title><source>Biofouling</source><year>2018</year><volume>34</volume><fpage>815</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1080/08927014.2018.1504926</pub-id><pub-id pub-id-type="pmid">30322278</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Bordini, E. A. F. et al. Antimicrobial effects of terpinen-4-ol against oral pathogens and its capacity for the modulation of gene expression. <italic toggle="yes">Biofouling</italic><bold>34</bold>, 815&#8211;825 (2018).<pub-id pub-id-type="pmid">30322278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08927014.2018.1504926</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maquera-Huacho</surname><given-names>PM</given-names></name><etal/></person-group><article-title><italic toggle="yes">Vitro</italic> antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces</article-title><source>Biofouling</source><year>2018</year><volume>34</volume><fpage>699</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1080/08927014.2018.1485892</pub-id><pub-id pub-id-type="pmid">30187780</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Maquera-Huacho, P. M. et al. <italic toggle="yes">Vitro</italic> antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces. <italic toggle="yes">Biofouling</italic><bold>34</bold>, 699&#8211;709 (2018).<pub-id pub-id-type="pmid">30187780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08927014.2018.1485892</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unlu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biofilm formation by <italic toggle="yes">Staphylococcus aureus</italic> strains and their control by selected phytochemicals</article-title><source>Int. J. Dairy. Technol.</source><year>2018</year><volume>71</volume><fpage>637</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1111/1471-0307.12520</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Unlu, A. et al. Biofilm formation by <italic toggle="yes">Staphylococcus aureus</italic> strains and their control by selected phytochemicals. <italic toggle="yes">Int. J. Dairy. Technol.</italic><bold>71</bold>, 637&#8211;646 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarkar</surname><given-names>T</given-names></name><name name-style="western"><surname>Bharadwaj</surname><given-names>KK</given-names></name><name name-style="western"><surname>Salauddin</surname><given-names>M</given-names></name><name name-style="western"><surname>Pti</surname><given-names>S</given-names></name><name name-style="western"><surname>Chakraborty</surname><given-names>R</given-names></name></person-group><article-title>Phytochemical characterization, antioxidant, anti-inflammatory, anti-diabetic properties, molecular docking, Pharmacokinetic profiling, and network Pharmacology analysis of the major phytoconstituents of Raw and differently dried <italic toggle="yes">Mangifera indica</italic> (himsagar cultivar): an <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in Silico</italic> investigations</article-title><source>Appl. Biochem. Biotechnol.</source><year>2022</year><volume>194</volume><fpage>950</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1007/s12010-021-03669-8</pub-id><pub-id pub-id-type="pmid">34591254</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Sarkar, T., Bharadwaj, K. K., Salauddin, M., Pti, S. &amp; Chakraborty, R. Phytochemical characterization, antioxidant, anti-inflammatory, anti-diabetic properties, molecular docking, Pharmacokinetic profiling, and network Pharmacology analysis of the major phytoconstituents of Raw and differently dried <italic toggle="yes">Mangifera indica</italic> (himsagar cultivar): an <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in Silico</italic> investigations. <italic toggle="yes">Appl. Biochem. Biotechnol.</italic><bold>194</bold>, 950&#8211;987 (2022).<pub-id pub-id-type="pmid">34591254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12010-021-03669-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubar</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Ester prodrugs of Ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and Docking studies</article-title><source>Med. Chem. Commun.</source><year>2011</year><volume>2</volume><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1039/C1MD00022E</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Dubar, F. C. et al. Ester prodrugs of Ciprofloxacin as DNA-gyrase inhibitors: Synthesis, antiparasitic evaluation and Docking studies. <italic toggle="yes">Med. Chem. Commun.</italic><bold>2</bold>, 430&#8211;435 (2011).</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hossen</surname><given-names>SMM</given-names></name><etal/></person-group><article-title>Antimicrobial potential, GCMS analysis and molecular Docking studies of <italic toggle="yes">Coelogyne suaveolens</italic> extracts: identification of bioactive compounds with mechanism of action</article-title><source>Biochem. Biophys. Rep.</source><year>2024</year><volume>37</volume><fpage>101648</fpage><pub-id pub-id-type="pmid">38314145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrep.2024.101648</pub-id><pub-id pub-id-type="pmcid">PMC10834465</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hossen, S. M. M. et al. Antimicrobial potential, GCMS analysis and molecular Docking studies of <italic toggle="yes">Coelogyne suaveolens</italic> extracts: Identification of bioactive compounds with mechanism of action. <italic toggle="yes">Biochem. Biophys. Rep.</italic><bold>37</bold>, 101648 (2024).<pub-id pub-id-type="pmid">38314145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrep.2024.101648</pub-id><pub-id pub-id-type="pmcid">PMC10834465</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bultum</surname><given-names>LE</given-names></name><name name-style="western"><surname>Tolossa</surname><given-names>GB</given-names></name><name name-style="western"><surname>Kim</surname><given-names>G</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>O</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name></person-group><article-title><italic toggle="yes">Silico</italic> activity and ADMET profiling of phytochemicals from Ethiopian Indigenous Aloes using pharmacophore models</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>22221</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-26446-x</pub-id><pub-id pub-id-type="pmid">36564437</pub-id><pub-id pub-id-type="pmcid">PMC9789083</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Bultum, L. E., Tolossa, G. B., Kim, G., Kwon, O. &amp; Lee, D. <italic toggle="yes">Silico</italic> activity and ADMET profiling of phytochemicals from Ethiopian Indigenous Aloes using pharmacophore models. <italic toggle="yes">Sci. Rep.</italic><bold>12</bold>, 22221 (2022).<pub-id pub-id-type="pmid">36564437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-022-26446-x</pub-id><pub-id pub-id-type="pmcid">PMC9789083</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van De Waterbeemd</surname><given-names>H</given-names></name><name name-style="western"><surname>Gifford</surname><given-names>E</given-names></name></person-group><article-title>ADMET <italic toggle="yes">in Silico</italic> modelling: towards prediction Paradise?</article-title><source>Nat. Rev. Drug Discov</source><year>2003</year><volume>2</volume><fpage>192</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1038/nrd1032</pub-id><pub-id pub-id-type="pmid">12612645</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Van De Waterbeemd, H. &amp; Gifford, E. ADMET <italic toggle="yes">in Silico</italic> modelling: Towards prediction Paradise? <italic toggle="yes">Nat. Rev. Drug Discov</italic>. <bold>2</bold>, 192&#8211;204 (2003).<pub-id pub-id-type="pmid">12612645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd1032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Musa</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Synthesis and Elucidation of strained galactopyronose esters as selective cyclooxygenase-2 inhibitor: A comprehensive computational approach</article-title><source>RSC Adv.</source><year>2024</year><volume>14</volume><fpage>30469</fpage><lpage>30481</lpage><pub-id pub-id-type="doi">10.1039/D4RA03520H</pub-id><pub-id pub-id-type="pmid">39318455</pub-id><pub-id pub-id-type="pmcid">PMC11421415</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Musa, M. S. et al. Synthesis and Elucidation of strained galactopyronose esters as selective cyclooxygenase-2 inhibitor: A comprehensive computational approach. <italic toggle="yes">RSC Adv.</italic><bold>14</bold>, 30469&#8211;30481 (2024).<pub-id pub-id-type="pmid">39318455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d4ra03520h</pub-id><pub-id pub-id-type="pmcid">PMC11421415</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Zhong, H. A. ADMET properties: Overview and current topics in <italic toggle="yes">Drug Des. Principles Appl.</italic> (ed. Zhou, S. F., Zhong, W. Z.) 113&#8211;133 (Omaha 2017).</mixed-citation></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazumder</surname><given-names>K</given-names></name><etal/></person-group><article-title>In Silico analysis and experimental evaluation of ester prodrugs of ketoprofen for oral delivery: with a view to reduce toxicity</article-title><source>Processes</source><year>2021</year><volume>9</volume><fpage>2221</fpage><pub-id pub-id-type="doi">10.3390/pr9122221</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Mazumder, K. et al. In Silico analysis and experimental evaluation of ester prodrugs of ketoprofen for oral delivery: With a view to reduce toxicity. <italic toggle="yes">Processes</italic><bold>9</bold>, 2221 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anzenbacher</surname><given-names>P</given-names></name><name name-style="western"><surname>Anzenbacherova</surname><given-names>E</given-names></name></person-group><article-title>Cytochromes P450 and metabolism of xenobiotics</article-title><source>Cell. Mol. Life Sci.</source><year>2001</year><volume>58</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1007/PL00000897</pub-id><pub-id pub-id-type="pmid">11437235</pub-id><pub-id pub-id-type="pmcid">PMC11337355</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Anzenbacher, P. &amp; Anzenbacherova, E. Cytochromes P450 and metabolism of xenobiotics. <italic toggle="yes">Cell. Mol. Life Sci.</italic><bold>58</bold>, 737&#8211;747 (2001).<pub-id pub-id-type="pmid">11437235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/PL00000897</pub-id><pub-id pub-id-type="pmcid">PMC11337355</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>